Molecular pathogenesis of a malformation syndrome associated with a pericentric chromosome 2 inversion by Cardoso, Manuela Pinto
2017 
UNIVERSIDADE DE LISBOA 
FACULDADE DE CIÊNCIAS 







Molecular pathogenesis of a malformation syndrome 













Dissertação orientada por: 
Doutor Dezsö David 





I would like to say “thank you!” to all the people that contributed in some way to this thesis. 
 
First and foremost, I would like to express my deepest gratitude to my supervisor, Dr. Dezsö David, 
for giving me the opportunity to work in his research group and for everything he taught me. Without 
his mentorship I would have never learned so much. 
 
I am grateful for Prof. Deodália Dias’s encouragement and support in all these years that I have been 
under her wings. 
 
I would like to extent my thanks to everyone at the National Health Institute Dr. Ricardo Jorge, for 
their continuous help in all stages of this thesis. To the team at Harvard Medical School, thank you for 
the technical assistance, and in special Dr. Cynthia Morton and Dr. Michael Talkowski. 
 
I am also grateful to Dr. Rui Gonçalves and Dr. João Freixo, who accompanied this case study and 
shared their medical knowledge. Of course, I am grateful for the family members for their 
involvement in this study. 
 
To my lab mates, a shout-out to them all! I really hold them dear for their help and the many laughs 
we shared every day. Thank you Mariana for being there literally since day one and for playing the 
role of a more mature counterpart. To Joana for being a glitter of fun and for reminding me of my 
curiosity in all things techy and kind of odd. To Sara for your positiveness. And Raquel, Carlos and 
Inês, though now so far away, it was a pleasure crossing paths with you. 
 
To my friends, both online and offline, for your words of encouragement. To Mapril, without whom I 
would be so very lost. 
 
At last, but obviously not the least, my dearest family, specially my very patient parents. They who 
silently watched over me and gave me the strength to face any adversity. They who so unwearyingly 
accepted my stubbornness. They are the guiding light in the darkest of hours. I do not say this often 
















Congenital malformation syndromes can be caused by genomic and/or chromosome rearrangements. 
It is difficult to establish the underlying causes of malformations because of their high level of 
complexity. Although balanced chromosome inversions are in most cases subclinical, those disrupting 
transcripts or affecting the genomic architecture at breakpoint regions may well be pathogenic. 
Currently, the lack of a fully annotated human genome hinders the predictability of the phonotypic 
consequences of such rearrangements. 
 
The aim of this study is the identification of potential candidate genes for a malformation syndrome in 
an individual with an apparently balanced maternally inherited pericentric chromosome inversion 
inv(2)(p16.1;q14.3)mat. The proband has severe congenital malformation with multiple psychomotor 
and developmental anomalies, dismorphism and autistic features. The parents are phenotypically 
normal. 
 
Classical cytogenetic methods are of low resolution, often in the magnitude of a 5 to 10 Mb. Whole-
genome Next-Generation Sequencing (NGS) of large-insert sequencing library (liWGS) has the 
capability to detect structural rearrangements with incomparably higher resolution, including cryptic 
alterations. As consequence, it was applied for the identification of inv(2)(p16.1;q14.3) breakpoints in 
the proband. Familial segregation analysis and definition of the inversion breakpoints at a nucleotide 
resolution were performed by amplification of junction fragments and Sanger sequencing. Genome 
and transcriptome array analysis were also carried out, for detection of additional genomic alterations 
and for gene expression profiling, respectively. 
 
Additionally, a possibly polymorphic duplication at 2q21.1, inherited from his father, was found. No 
apparent pathogenic genomic imbalances were identified in the proband. 
 
The inversion breakpoints are located at chr2:55,935,064 and chr2:123,767,685 (GRCh37), 
respectively, in 2p16.1 and 2q14.3. The inv2p16.1 breakpoint is flanked 14 kb proximal by the gene 
polyribonucleotide nucleotidyltransferase 1 (PNPT1; chr2:55,861,198-55,921,045, GRCh37; OMIM 
*610316) and 172 kb distal by EGF containing fibulin-like extracellular matrix protein 1 (EFEMP1; 
chr2:56,093,097-56,151,298, GRCh37; OMIM *601548). PNPT1, highly expressed in mice cochlea, 
has been associated with deafness (OMIM #614934) and with combined oxidative phosphorylation 
deficiency (OMIM #614932), both autosomal recessive. Meanwhile, the autosomal dominant Doyne 
honeycomb retinal dystrophy (OMIM #126600) is reported to be associated with mutations in 
EFEMP1. This gene is essential for the formation of elastic fibers in connective tissue. 
 
The 2q14.3 breakpoint is in a gene-poor region. Located 1.2 Mb proximal to the breakpoint is translin 
(TSN; chr2:122,513,120-122,525,428, GRCh37; OMIM *600575). Involved in DNA damage repair 
and RNA trafficking in neurons, TSN codes for a protein that specifically binds to breakpoint 
junctions of translocations in acute leukemia. The gene contactin-associated protein-like 5 
(CNTNAP5; chr2:124,782,863-125,672,953, GRCh37; OMIM *610519) is localized 1 Mb, distal. 
CNTNAP5 is involved in cell adhesion and intercellular communication. Susceptibility to autistic 
syndromes has been suspected. 
 
The above described breakpoints at nucleotide resolution are the same in the proband’s mother, and 
did not directly disrupt any gene.  
 
III 
Publicly available clinical information on alterations affecting the inversion flanking genes revealed 
no major similarity with the proband’s phenotype. Furthermore, no significant alteration in their 
expression level was observed. In-depth analysis of genome-wide expression data is in progress. 
 
Based on these findings, the causal relationship between clinical phenotype and the 
inv(2)(p16.1;q14.3) is most likely excluded, since the inversion is most likely non-pathogenic. 
Therefore it is not yet possible to identity the underlying genetic cause of the malformation syndrome 
reported in this subject. Whole-exome sequencing is proposed as a future task to detect the disease 
causing alteration. 
 
This study highlights the application of NGS-based methodology, with its capability in mapping 
chromosome inversion breakpoints at a very high resolution. Large scale application of this approach 
will represent a hallmark in the characterization of congenital malformations associated with 
structural chromosomal abnormalities. 
 
This study was supported by Fundação para a Ciência e a Tecnologia project PTDC/SAU-





























As síndromes de malformação congénitas são um dos principais grupos de patologias que afetam 
neonatos e crianças em países desenvolvidos. Muitos destes casos têm como base genética os arranjos 
genómicos ou cromossómicos. No entanto, por norma, devido à complexidade inerente às síndromes 
de malformação, é difícil e laborioso identificar com exatidão a alteração molecular que lhes deu 
origem. Aliado à inexistência atual de um genoma humano completamente anotado, torna-se 
complicado a compreensão e a previsão das consequências fenotípicas dos rearranjos cromossómicos.  
 
As inversões cromossómicas são rearranjos que ocorrem quando dois pontos de quebra ocorrem num 
mesmo cromossoma e são reinseridos invertidos, sem alteração de número de cópia. Normalmente as 
inversões são subclínicas, sem um fenótipo clínico associado. Se estes forem transmitidos a mais de 
1% de uma dada população, tratam-se de polimorfismos. Se um rearranjo afectar transcritos ou a 
arquitetura genética junto dos pontos de quebra, perturbando assim o normal funcionamento dos 
genes, sobretudo os de expressão indispensável, este estará envolvido na etiologia de uma patologia 
potencialmente grave. Comparado com outros rearranjos cromossómicos, são poucas as inversões 
atualmente detalhadamente caracterizadas, frequentemente devido a dificuldades técnicas 
relacionadas com regiões repetitivas, frequentes nos pontos de quebra das inversões.  
 
Metodologias clássicas de citogenética são de baixa resolução e por vezes incapazes de identificar 
determinadas anomalias estruturais. As tecnologias atualmente mais avançadas para o estudo de 
rearranjos incluem microarrays genómicos, ideal na análise de variações no número de cópias, e a 
sequenciação de próxima geração (NGS), mais concretamente sequenciação pangenómica, para a 
generalidade dos rearranjos cromossómicos. Esta última tem a particularidade de ser eficiente na 
identificação de alterações crípticas, de oferecer uma potencial resolução bastante elevada (em certos 
casos nucleotídica) e de gerar grande quantidade de dados rapidamente. Das plataformas NGS 
existentes, as mais aptas para a análise de inversões envolvem a construção de bibliotecas mate-pair 
de grandes insertos, cuja distância entre pares de leitura é de 2 a 6 kb, permitindo superar dificuldades 
técnicas com zonas repetitivas e pequenas alterações junto aos pontos de quebra.  
 
Esta tese pretende identificar as alterações moleculares responsáveis pela síndrome de malformação 
congénita num indivíduo portador de uma inversão cromossómica pericêntrica aparentemente 
equilibrada de origem materna. 
 
O caso índex, portador da síndrome de malformação, apresenta acentuado atraso de desenvolvimento 
mental e psicomotor, dismorfia facial e perturbações do espectro do autismo. Ele tem muito baixo 
peso e altura para a idade. Foram também diagnosticadas cardiopatias, criptorquidia, escoliose e 
hipotonia generalizada. Estudos citogenéticos detetaram a existência de uma inversão pericêntrica no 
cromossoma 2, também encontrada na mãe. Os pais têm fenótipo aparentemente normal. 
 
Primeiramente, procedeu-se à identificação de alterações estruturais desequilibradas no indivíduo 
índex. Foram detetaram várias alterações de número de cópia, na maioria pequenas (< 100kb) e sem 
envolver genes OMIM, com a exceção da duplicação de 590 kb em 2q21.1. Os genes na duplicação 
não aparentam estar relacionados com o fenótipo observado. Ademais, foi detetado uma duplicação de 
610 kb no pai nesta mesma região genómica, sugerindo que se trata de uma alteração de origem 




Sequenciação pangenómica de grandes insertos (large-insert whole-genome sequencing) usando ácido 
desoxirribonucleico (ADN) do caso índex foi realizada para a identificação dos pontos de quebra da 
inversão no cromossoma 2. Uma vez delimitado a região dos pontos de quebra por NGS, foram 
desenhados oligonucleotídeos específicos para a amplificação dos fragmentos de junção e, 
seguidamente, procedeu-se à análise de segregação familiar e determinação nucleotídica dos pontos 
de quebra através de sequenciação Sanger. O estudo do perfil de expressão genética foi feito com 
Human Transcriptome Assay (HTA 2.0) da Affymetrix, utilizando ácido desoxirribonucleico (ARN) 
da linha celular linfoblastóide do indivíduo índex. 
 
Os dados obtidos por NGS permitiram a redefinição da localização genómica da inversão. O cariótipo 
do caso índex foi assim redefinido como 46, XY, inv(2)(p16.1q14.3)mat.  
 
Os pontos de quebra da inversão no cromossoma 2, no caso índex e na sua mãe, foram determinados. 
Estes localizam-se na posição chr2:55,935,064 e chr2:123,767,685 (GRCh37), respetivamente, nas 
bandas p16.1 e q14.3. Na sequência invertida ocorreu a deleção de 5 bases. Os pontos de quebra da 
inversão são iguais em ambos os indivíduos, sem quaisquer alterações detetadas nos fragmentos de 
junção. Segundo a nomenclatura baseada em citogenética de próxima geração, esta inversão é descrita 
como seq[GRCh37] inv(2)(pter→2p16.1(55,935,06{1-3})::2q14.3(123,767,68{3-1})→2p16.1 
(55,935,06{5-4})::2q14.3(123,767,68{4-5})→qter). 
  
Os pontos de quebra não interrompem diretamente genes conhecidos. Em inv2p16.1, este é 
flanqueado a 5’ pelo gene polirribonucleotídeo nucleotidiltransferase 1 (PNPT1; chr2:55,861,198-
55,921,045, GRCh37; OMIM *610316), e a 3’ pelo gene proteína 1 da matriz extracelular tipo-
fibulina contendo EGF (EFEMP1; chr2:56,093,097-56,151,298, GRCh37; OMIM *601548) a 158 kb. 
O PNPT1 está envolvido na cadeia respiratória mitocondrial. Mutações em homozigotia foram 
associadas com deficiência na fosforilação oxidativa (OMIM #614932), originando nomeadamente 
encefalopatias, e com a surdez hereditária autossómica recessiva 70 (OMIM #614934). Em 
murganhos, tem expressão acentuada na cóclea. EFEMP1 é essencial para a correta formação de 
fibras elásticas em tecido conjuntivo, tendo elevada expressão nos pulmões e esófago em murganhos, 
e baixa no cérebro e coração. Mutações neste gene estão descritas como causa genética da distrofia da 
retina de Doyne (OMIM #126600), patologia autossómica dominante com início na segunda década 
de vida, causando perda progressiva de visão. 
 
O ponto de quebra em inv2q14.3 situa-se numa região pobre em genes. O gene translina (TSN; 
chr2:122,513,120-122,525,428, GRCh37; OMIM *600575) franqueia o ponto de quebra 
proximamente a 1240 kb, enquanto o gene tipo-proteína associada à contatina 5 (CNTNAP5; 
chr2:124,782,863-125,672,953, GRCh37; OMIM *610519) localiza-se 1020 kb distal do ponto de 
quebra. TSN codifica uma proteína que reconhece sequências-alvo em junções de pontos de quebra de 
translocações em doentes com leucemia, e está envolvido no mecanismo de reparação de ADN e 
transporte de ARN em neurónios. Em murganhos, expressa-se preferencialmente no tecido adiposo. O 
CNTNAP5 produz uma proteína que atua no sistema nervoso como moléculas de adesão celular e de 
recetor na comunicação intercelular. Em murganhos, expressa-se predominantemente no sistema 
nervoso. Existe suspeita de que mutações pontuais possam conferir suscetibilidade a comportamentos 
do espectro do autismo. 
 
Quanto à expressão genética, os resultados mostraram que os genes que flanqueiam a inversão não 
aparentam ter nível de expressão significativamente alterada comparativamente com os controlos. O 
estudo aprofundado de expressão a nível genómico está a decorrer. 
 
Os restantes genes próximos dos pontos de quebra da inversão relevaram baixa probabilidade de 
serem as alterações causadoras do fenótipo, nomeadamente a nível das doenças associadas.  
VI 
 
Tendo em conta os resultados obtidos, especialmente a confirmação da origem materna da inversão, 
esta alteração não aparenta ser a principal e única causa molecular do fenótipo. Ademais, esta 
conclusão é suportada pela pouca sobreposição clínica dos genes flanqueadores com a síndrome de 
malformação congénita, e da expressão génica aparentemente não alterada. 
 
Assim, atualmente, a relação causal entre o fenótipo observado e a inversão no cromossoma 2 foi 
excluída. Esta inversão é muito provavelmente não-patogénica por si só. Até ao momento e com os 
dados disponíveis, não foi possível identificar genes candidatos nem as alterações moleculares por 
detrás da síndrome de malformação congénita no caso índex. Informação médica disponível exclui 
influência de fatores ambientais na embriogénese. 
 
Futuramente, sugere-se recorrer à sequenciação do exoma, visto que tem uma sensibilidade muito 
superior para a deteção de pequenas em exões, potencialmente não detestáveis pelas abordagens até 
ao momento utilizadas. Adicionalmente, o estudo nos restantes membros da família permitirão obter 
uma melhor visão sobre a segregação familiar. 
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1.1. The Chromosomes 
 
Since ancient times that humans inquired about the inheritance of traits from generation to generation. 
It was not until 1860 that the existence of a biological element of heredity was proposed. In 1869, the 
deoxyribonucleic acid (DNA) fiber was discovered, with its role in heredity finally confirmed in 1952 
and its structure famously uncovered a year later (Bhat and Wani 2017; Dahm 2007; Watson and 
Crick 1953). 
 
The long chain of DNA is associated with proteins called histones that compact it, protect it and help 
in the correct function of the DNA. The DNA and the associated components are packaged into 
thread-like structures, the chromatin, which in turn make up the chromosomes (Paulson and 
Vagnarelli 2011). The word chromosome derives from the Greek words for “color” and “body”, due 
to their strong coloration when stained with specific dyes. Chromosomes are the structures that hold 
most of an organism’ genes, the individual instructions for development and function, governing 
every characteristic of an organism (GHR 2014). Over time, the genetic information coded in the 
DNA is transmitted from parent cells to daughter cells, as well as from parent to child (Czepulkowski 
2001).  
 
Each chromosome has a primary constriction called the centromere, dividing it into two sections, 
known as arms, the short p arm and the long q arm. At the extremity of each arm is a region called 
telomere (GHR 2014; Young 2005). A chromosome can be classified as metacentric, submetacentric 
or acrocentric depending on whether the centromere is central, slightly off-center or almost at the 
telomere, respectively (Czepulkowski 2001). 
 
The number of chromosomes varies between species and, within an organism, whether it is a gamete 
or a somatic cell, being respectively haploid and diploid for human (Czepulkowski 2001). The normal 
human chromosome complement consist of 46 chromosomes (23 pairs), divided into 44 autosomes 
and a pair of sex chromosomes (Young 2005). Females have two copies of the X chromosome, while 
males have one X and one Y chromosome. The 22 autosome pairs are numbered by size. When lined 
up in pairs from the largest to the smallest chromosome, with the short arms at top, it is called a 
karyotype (GHR 2014). 
 
 
1.2. Chromosomal Anomalies 
 
Chromosomal anomalies traditionally refer to alterations in the chromosome that are generally large 
enough to be visible under a light microscope, which has an average resolution of 5 to 10 Mb 
(Czepulkowski 2001). With the development of much more sensitive technologies, gradually the 
criteria for the designation of structural anomalies have been shifting to a magnitude of thousands of 
bases (Vergult et al. 2014). 
 
These anomalies are classified as either numerical or structural and may involve more than one 
chromosome. Numerical anomalies are deviations from the normal state of diploidy. In another hand, 
structural anomalies, also called chromosomal rearrangements, changes the very structure of one or 
2 
more chromosomes, such as the case of translocation, deletions or inversions (Young 2005). The 
anomalies may cause profound alterations that in turn may disrupt normal cell function, if such events 
could not be rapidly mended correctly by the DNA repairing mechanisms (Czepulkowski 2001). 
 
 
1.2.1. Structural Anomalies 
 
A structural rearrangement encompasses several events that together alter the chromosome 
morphology. These events are caused by double strand breaks in the DNA, usually at two different 
loci, followed by a rejoining of the broken ends to produce a new arrangement with the corresponding 
consequences (Griffiths et al. 1999). When these rearrangements involve more than two chromosomes 
or breakpoints they are termed complex chromosome rearrangements (Liu et al. 2011).  
 
A variety of cellular processes can act as the source that give rise to DNA breaks. During DNA 
replication, for example, if a replication fork passes through a template that contains a single-stranded 
break, it will be converted into a double-stranded break on one of the sister chromatid thus creating a 
full breakpoint (van Gent et al. 2001). External factors such as ionizing radiation are also capable of 
inducing breaks. Several mechanisms are available to repair these damages, but they can sometimes 
lead to other small errors upon conclusion: homologous recombination repair precisely restores the 
original sequence at the break without modifications; single-strand annealing could lead to interstitial 
deletions; and, finally, nonhomologous DNA end joining connects two broken ends directly and can 
also generate small alterations (Obe et al. 2002). 
 
Chromosomal structural rearrangements can be classified as imbalanced or balanced, depending on 
whether there were loss or gain of DNA. Imbalanced rearrangements alter the quantity of genetic 
material in the affected chromosomes and thus is possible to disrupt normal gene balance, for 
example, deletions and duplications. In contrast, balanced rearrangements are copy number neutral 
events that change the chromosomal gene order and relative locations without overall net gain or loss 
of DNA, usually referring to reciprocal translocations and inversions (Griffiths et al. 1999). Note that 
these classifications are simply broad generalizations, since even seemingly balanced rearrangements 
could sometimes generate small deletions or duplications at the breakpoint regions as repercussion of 
the repair process (Young 2005). 
 
 
1.2.1.1. Copy Number Variation 
 
The term copy number variation (CNV) denotes a copy number change of DNA fragments sized 1 kb 
or above, be them duplicated and deleted. CNV often occur in regions reported to contain, or be 
flanked by, large homologous repeats (Freeman et al. 2006), and are an abundant form of variation in 
the human genome (Feuk 2010). 
 
Duplication is a repetition of a genomic region, resulting in a gain of extra genetic material. A 
dupication usually occurs by unequal crossing-over between homologous chromosomes or sister 
chromatids, as well as abnormal meiotic segregation in a translocation or meiotic crossing-over in an 
inversion carrier (Czepulkowski 2001; Luthardt and Keitges 2001). A duplication is tandem if the 
duplicated segment is adjacent to the original copy, nontandem if it is nonadjacent, whether residing 
3 
in the same chromosome or inserted into another one, or terminal duplication if it affected the 
telomere (Bhat and Wani 2017). 
 
On the contrary, a deletion is the loss of a DNA segment. Terminal deletions result from a single 
break within one chromosome arm with loss of material distal to the break, while interstitial deletions 
involve two breaks with loss of the material in between (Griffiths et al. 1999; Luthardt and Keitges 
2001). 
 
In general, duplications are less harmful than deletions due to the fact that a higher copy number of 
genes and regulatory elements are better tolerated by the cell then outright complete removal. Some 
duplications were even reported as potentially benign, but they may nonetheless be associated with 
some degree of phenotypical anomaly (Czepulkowski 2001). Additionally, larger CNV are often 
located in repeat-rich regions such as telomeres, centromeres and heterochromatin, away from high 
density protein-coding genes regions (Freeman et al. 2006). The degree of clinical severity is 
generally correlated with size of the duplicated or deleted segment (Luthardt and Keitges 2001; 
Griffiths et al. 1999).  
 
Chromosomal structural variations, both balanced and imbalanced, may overlap with or locate nearby 
segmental duplications (SD), significantly more often than expected by chance alone. SD are blocks 
of DNA, ranging from 1 to 400 kb in length, present more than once in the genome and sharing over 
90% sequence identity, found either on the same chromosome or on different, nonhomologous 
chromosomes (Freeman et al. 2006). Studies observed a significant association between the location 
of SD and regions of genomic instability that may lead to chromosomal rearrangements. The presence 
of large, highly homologous flanking repeats seems to predispose these regions to recurrent 
alterations (Sharp et al. 2005). As such, SD are sometimes found to be overrepresented near structural 
variation sites (Antonacci et al. 2009). 
 
 
1.2.1.2. Balanced Rearrangements 
 
Chromosomal translocations and inversions are generally balanced rearrangements that involve a 
break at two or more sites, and afterwards an incorrect reunion of the resulting fragments, without loss 
of genetic material. They occur with a frequency of 1 in every 2000 live births (Utami et al. 2014; 
Warburton 1991). 
 
Translocations occurs when two nonhomologous chromosomes are each broken once, creating 
acentric fragments that later connect, forming a structure known as pachytene quadrivalent. When this 
temporary construction breaks off, their arms swap, trading places. Hence translocations are 
reciprocal in nature (Griffiths et al. 1999; Nambiar and Raghavan 2011). Inversions happen when two 
breakpoints occur in one single chromosome, and the region in-between reverses and reinserts into the 
opposite site (Griffiths et al. 1999; Young 2005). Chromosomal inversions will be further discussed in 







1.3. On Chromosomal Inversions 
 
1.3.1. Molecular Anatomy of an Inversion 
 
Contrary to early predictions from classical cytogenetics, since their first identification in the 1920s 
inversions have been increasingly recognized as a relatively common source of variation (Alves et al. 
2012; Kirkpatrick 2010). Inversions are indeed among the most common human constitutional 
karyotype anomalies detected in cytogenetic laboratories (Feuk 2010), found in about 2% of all 
humans and comprise approximately 10% of all structural rearrangements (Bhat and Wani 2017; 
Fickelscher et al. 2007; Muss and Schwanitz 2007). The frequency of de novo inversions identified is 
around 1 in 10,000 cases, with the risk of congenital anomalies in such cases being as high as 9.4% 
(Warburton 1991). Currently, as of February 2017, for humans, the National Center for Biotechnology 
Information's (NCBI) database of genomic structural variation (dbVar, https://www.ncbi.nlm.nih.gov/ 
dbvar) reports 514 inversions validated by more than one experimental methods, such as FISH or 
microarrays.  
 
Chromosome inversions, like other structural rearrangements, are often generated by non-allelic 
homologous recombination between inverted repeats or errors in the DNA repair mechanisms. The 
events create breaks that detach a segment of DNA and ultimately allow it to rotate itself before the 
repair mechanisms could enter once again in action to reunite the extremities (Puig et al. 2015b), as 
illustrated in Figure 1.1.  
 
Large inversions are primary formed by non-allelic homologous recombination during the reparation 
process, where it involves regions of SD, since duplicated sequences can be inserted in an inverted 
orientation with respect to each other. However, for smaller inversions of under 10 kb the process 
remains uncertain, and more nucleotide-level information on breakpoints are needed to better 





Figure 1.1. Basic mechanisms for the origin of inversions (adapted from Griffiths et al. 1999).  
A) Chromosome break then rejoining 
B) Crossing-over between highly repetitive regions  
Chromosome regions are numbered 1 through 4. 
 
 
Following an inversion event, the overall genetic behavior of the chromosome is determined by the 
location of the centromere relative to the inverted segment. If the centromere is inside the inverted 
segment then the inversion is said to be pericentric, whereas if it is outside then the inversion is 
paracentric (Griffiths et al. 1999). 
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Pericentric inversions can be detected through new arm ratios (Griffiths et al. 1999), but not 
paracentric inversions, which can only be detected microscopically by banding or by other 
chromosome landmarks if the inversion includes more than one band (Griffiths et al. 2000). Some 
breakpoints occur preferentially in certain regions, or hotspots, easing the detection of recurrent or 
suspected inversions (Muss and Schwanitz 2007). 
 
During meiosis, a chromosome that houses an inversion follows one of two outcomes: either there is 
crossing-over between chromatids or there is not. If there isn’t, then each resulting gamete will inherit 
a balanced rearrangement (Young 2005). But, if a cross-over does occurs between two nonsister 
chromatids within the inversion loop, like in the case of paracentric inversions, it will produce 
homologous centromeres in a dicentric bridge and an acentric fragment (Griffiths et al. 1999; Young 
2005). As the chromosomes separate in anaphase I, the centromeres remain linked by the bridge, but 
tension will eventually break it at a random location, forming two chromosomes with terminal 
deletion. Since the acentric fragment cannot pair with its homologous due to its lack of a centromere, 
and the remaining fragment has two, both are unstable during mitoses and will be lost (Griffiths et al. 
2000; Young 2005). This unviability means that paracentric inversions do not warrant indication for 
prenatal diagnosis, as the gametes containing deleted chromosomes are usually inviable because the 
crossing-over produces lethal products (Czepulkowski 2001), and are as such incompatible with life. 
In the contrary, pericentric inversion has no such problem with its single centromere. Still, they can 
produce recombinants with duplication and deletions, with its viability dependent upon the size of the 
unbalanced segments (Luthardt and Keitges 2001). 
 
The decreased overall lethality and the comparatively ease of identification are the main reasons 
behind the higher detection frequency of pericentric inversions over paracentric inversions, 66% 
compared to just 34% (Luthardt and Keitges 2001).  
 
Characterization of inversions represents a particularly remarkable challenge, especially in complex 
genomes, due to their balanced nature and breakpoints that are often located within highly identical 
inverted repeated sequences (Puig et al. 2015). Furthermore, cryptic imbalances can occur in half of 
individuals with a non-normal phenotype that harbors an alteration, increasing the overall complexity 
(Ordulu et al. 2016). A study conducted on 40 subjects with apparently balanced alterations, some of 
which are inversions, revealed cryptic rearrangements in nearly 40% of these cases (Higgins et al. 
2008; Ordulu et al. 2016).  
 
Due to their technical challenges, the study of inversions frequently fall out of favor for other easier to 
detect or clinically more severe or frequent variants, such as CNV and translocations. It means that 
much remain unknown about chromosomal inversions (Puig et al. 2015). 
 
 
1.3.2. Polymorphic chromosome inversions 
 
A structural chromosome anomaly is considered polymorphic if its allele frequency is above 1% in a 
given population (Freeman et al. 2006). In 1926, evidence of polymorphic inversions was found in 
Drosophila melanogaster (Corbett-Detig et al. 2012) and since then they were found to segregate in 
multiple species and are considered some of the most fascinating paradigms in evolutionary biology 
(Puig et al. 2015). Over time, knowledge about the genetic implication of polymorphic 
rearrangements in the human genome has grown rapidly, including that of inversions. The advent of 
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genome-scanning technologies has enabled the discovery of thousands of polymorphisms in 
phenotypically normal individuals (Antonacci et al. 2009). 
 
Inversion polymorphisms are a universal phenomenon (Corbett-Detig et al. 2012). However, despite 
being present in virtually all species and extensively studied in model organisms, they are yet to be 
well characterized in humans (Cáceres et al. 2015) and a comprehensive map of inversions remains to 
be determined.  
 
Because of complexity of the genomic regions where inversions typically occur (Cáceres et al. 2015) 
and the challenges related to the absence of affordable high-throughput methods, relatively few 
polymorphisms have been detected and characterized in humans (Antonacci et al. 2009), the majority 
falling within the 10 to 100 kb size interval (Alves et al. 2012). 
 
Most of the currently known examples of polymorphic inversions came indirectly from studies of 
human diseases, where they have been identified from their association with susceptibilities to 
recurrent genomic rearrangements (Antonacci et al. 2009), or by their relationships with complex 
genetic disorders (Cáceres et al. 2012). Genome-wide single nucleotide polymorphism (SNP) data 
suggest that there could be hundreds of such inversions yet to be found in humans alone (Cáceres et 
al. 2015). As of February 2017, the invFest database (http://invfestdb.uab.cat/), which aims to store 
published polymorphic inversions in the human genome, reports 91 polymorphic inversion validated 
experimentally by direct observation, the majority of which are intergenic (Martínez-Fundichely et al. 
2014). 
 
To date, very few polymorphic inversions not directly related to pathology have been studied 
(Entesarian et al. 2008). Although not pathological, some of them seem to be connected to gene 
expression or even associated with certain phenotypes, like infertility and neurodegenerative diseases. 
Their mechanisms, however, are still not well elucidated (Puig et al. 2015a). One of the exceptions to 
the general obscurity is the well-studied polymorphic inversion located at 8p23, spanning 4.7 Mb and 
one of the largest know in humans (Salm et al. 2012), found in 26% of Europeans and 27% of 
Japanese individuals. Another example is the chromosome 4 inversion, of about 6 Mb in size and 
found in 12.5% of healthy controls (Feuk 2010). For most analyzed polymorphisms, there is no 
significant differences in the frequency of inversion alleles between ethnic groups (Antonacci et al. 
2009), suggesting that these events have been occurring since ancient human history (Salm et al. 
2012), showing a weak negative effect on reproductive fitness (Feuk 2010).  
 
 
1.3.3. Inversions in chromosome 2 
 
Chromosome 2 displays the highest recombination frequency for euchromatic pericentric inversions, 
at 11% (Muss and Schwanitz 2007). One of the most frequently observed inversion in humans is the 
familial inv(2)(p11q13), considered to be of no clinical significance (Feuk 2010) and is found in 0.1% 
of North Europeans (Entesarian et al. 2008). Over half of reported chromosome 2 inversions have 
their breakpoints located in p11.2 and q13 (Yakut et al. 2015) 
 
It is estimated that one in every hundred newborns carries a pericentric inversion (Czepulkowski 
2001). The incidence of pericentric inversions in chromosome 2 in the general population was 
reported to be between 0.0001% and 0.013%. Despite their large size, these inversions are usually 
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nonpathological. But, depending on its location, studies generally report some association with mental 
retardation, congenital malformations or reproductive failure (Djalali et al. 1986). 
 
Inversions with clinical significance are not as frequently described in depth as other chromosomal 
rearrangements. This could be to the increased difficulty in characterizing inversions, especially those 
with cryptic rearrangements (Puig et al. 2015), as mentioned above. The pericentric inversion 
inv(2)(p23.3q24.3) was recently reported in an elderly individual with chronic thrombocytopenia and 
anemia (Kjeldsen 2015). And the pericentric inversion inv(2)(p15q21), described by Cohen et al. 
(1975), was considered of uncertain clinical significance in the observed Turner syndrome. 
 
As of February 2017, in dbVar (http://www.ncbi.nlm.nih.gov/dbvar), there are only 24 validated 
chromosome 2 inversions reported in humans.  
 
 
1.4. Phenotypical consequences of chromosomal anomalies 
 
1.4.1. Congenital malformations associated with chromosomal rearrangements 
 
Congenital malformations are defects in morphogenesis during embryogenesis that are identifiable at 
pregnancy or at birth. Although these malformations are often caused by genetic factors, 
environmental factors can also interfere with otherwise normal development (Corsello and Giuffrè 
2012; Raymond and Tarpey 2006).  
 
Chromosome anomalies are a major contributor of genetic diseases, resulting in heavy burden for 
public health systems worldwide (Corsello and Giuffrè 2012). They can cause an extensive array of 
clinical phenotypes such as infertility, congenital malformations syndrome, developmental delay, 
mental retardation and even autism spectrum disorder (ASD) (Raymond and Tarpey 2006; Vergult et 
al. 2014). It is very important to understand the molecular basis of these anomalies in order to 
improve diagnosis and treatment. 
 
It is reported that the risk of congenital anomalies in newborns with apparently balanced 
chromosomal rearrangements is up to three times higher than in the general population, for which the 
risk of anomalies is between 2 and 3% (Warburton 1991).  
 
These anomalies have been associated with over 60 identifiable syndromes, and are detected in 50% 
of spontaneous abortions, 6% of stillbirths, 5% of couples with two or more miscarriages and 
approximately 0.5% of newborns. The frequency of anomaly increases with the mother’s age, and for 
women over 35 years old it reaches 2% of all pregnancies (Le Caignec et al. 2005; Luthardt and 
Keitges 2001). Furthermore, the risk for congenital malformations is even higher in consanguineous 
unions (Leonard 2016). 
 
A starting event, like the occurrence of alteration or mere random accidents during the formation of 
reproductive cells or in early fetal development, may originate a series of dysmorphogenetic processes 
producing a cascade of defects and malformations. The severity of these malformations depends on 
the nature, size and location of original event and how it influenced the downstream processes 
(Corsello and Giuffrè 2012). These changes in chromosome structure due to rearrangements can cause 
chromosomal disorders that can be inherited (GHR 2014). Studies observed that familial transmission 
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of chromosomal rearrangements is mainly through female carriers (Batista et al. 1994), though the 
reason behind this phenomenon is unclear. 
 
Studies report that chromosomal structural anomalies can produce similar phenotype to those caused 
by point mutations, if directly disrupted important genes or by some position effect as consequence of 
rearrangement, in some cases easing their analysis (MacIntyre et al. 2003). Whenever a balanced 
rearrangement occurs in a non-coding region, however, predicting pathogenic consequences can 
become very challenging if the evaluation focuses only on the nearest genes (Ordulu et al. 2016). 
Also, since balanced rearrangements change the genomic localizations and order of genes, they can 
have profound effects on their expression, even if they remained intact (Avelar et al. 2013). They can 
also modify gene pattern activity by dissociating them from its original regulatory elements and/or 
placing it under the control of other regulatory elements (David et al. 2013; Mihelec et al. 2008; Puig 
et al. 2015). Because of all the positional changes, it is recommended to analyze not only disrupted 
gene-regulatory elements pairs but also interaction that may be happening between the primary 
alteration and any other alterations. 
 
Phenotypically normal carriers of balanced rearrangements can produce an offspring with imbalance, 
especially if it involves a large region (Czepulkowski 2001). As a general rule, any degree of 
chromosome imbalance involving one or more of the autosomes will have serious adverse effects 
(Young 2005). Still, even an apparently balanced alteration can be associated with severe 
malformations. About 6% of de novo balanced rearrangements detected at amniocentesis are 
associated with an abnormal phenotype (Tabet et al. 2015), and many were linked to clinical features 
like psychomotor developmental delay, dismorphism, defects of heart formation and ASD (Raymond 
and Tarpey 2006; Utami et al. 2014).  
 
In individuals with ASD, chromosomal anomalies were detected in 7.4% of cases (El-Baz et al. 2016), 
some of which known to be implicated in the phenotype (Tabet et al. 2015). Actually, the large 
number of genes identified as associated with complex clinical features, like psychomotor 
developmental delay, suggests that it should be the common consequence of many affected cellular 
processes and that no single mechanism is likely to be the only cause of phenotype (Raymond and 
Tarpey 2006). Considering that the rate of chromosomal rearrangement in people with mild learning 
disability may be as high as 19% (MacIntyre et al. 2003), if the alteration is in some way linked to 
disability, the number of possible molecular causes are certainly very high.  
 
 
1.4.2. Clinical Implication of Inversions 
 
Biologically, even large inversions are likely to be neutral, without obvious phenotypic consequences 
(Feuk 2010). Studies have also shown that both carriers and non-carriers of inversions have a similar 
rate of miscarriages and death in the neonatal period (Muss and Schwanitz 2007), despite the selective 
forces against excessive harm due to genomic changes early in development (Kirkpatrick et al. 2011).  
 
Families carrying only small and sub-clinical inversions may transmit the aberrant chromosome 
through several generations and never be detected, as there may be no reason for cytogenetic 
screening. Among healthy offspring of inversion carriers, there is an expected 1:1 ratio of them being 
inversion carriers to noncarriers (Honeywell et al. 2012). Nonetheless, the majority of carriers of 
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inversions have no clinically significant phenotype, both in the heterozygous and in the rare 
homozygous state (Muss and Schwanitz 2007). 
 
Carriers of balanced rearrangements are usually phenotypically normal if no essential genes are 
affected by the breakpoints or if it does not fall between a gene and its transcription regulatory 
elements. (Feuk 2010; Luthardt and Keitges 2001). Since inversions typically do not result in changes 
in copy number, only of orientation, they could appear to be neutral variants without phenotypic 
effects of clinical significance. However, in reality, some inversion are far from harmless. For 
example, they are potential mechanical causes of subfertility (Alves et al. 2012) and another well-
known example is the disease-causing recurrent inversion affection 3’ region of the F8 (exon 22 to 
26) is found in 43% of patients with severe Hemophilia A (Feuk 2010).  
 
If one of the breakpoints is within or closely adjacent to a gene of essential function, then it could act 
as a lethal gene mutation and result in a pathology (Griffiths et al. 2000; Muss and Schwanitz 2007), 
but it still highly depends on the gene’s role and the mechanisms acting on it. Genes within an 
inversion can be entirely unaffected, unlike those within CNV, which are always affected by a dosage 
imbalance (Feuk 2010).  
 
However, compared to the downstream effects of CNV, the genes disrupted by inversions are 
presumably more severely affected, due to increased risk of protein truncation or heterozygous 
inactivation of the affected allele (Utami et al. 2014). For example, an inversion truncates the X-
linked IDS gene in 13% of Hunter syndrome patients, potentially causing or exacerbating the disease 
(Puig et al. 2015b). Very rarely, it is possible that the rejoining of two partial, truncated genes can 
originate new protein or promoter, in other words, gene fusion. Depending on the resulting products, 
they might be pathogenic, neutral or even benign, giving rise to new functions (Griffiths et al. 1999; 
Kloosterman and Hochstenbach 2014).  
 
Heterozygous inversion generally are not linked to disease nor do the carriers show adverse 
phenotype. But the carriers produce the expected array of abnormal meiotic products, and often also 
have mechanical pairing problems in the region of the inversion, reducing the frequency of crossing-
over and leading to an increased risk for chromosomally abnormal offspring (Griffiths et al. 2000; 
Luthardt and Keitges 2001). An inversion cannot be bred to homozygosity if it is lethal, but it may 
still be viable if only nonessential genes were affected (Griffiths et al. 1999). In such cases, the 
inverted chromosomes pair and crossover normally, the meiotic products are viable, and the linkage 
map will show the inverted gene order (Griffiths et al. 2000). While inversions with an apparent 
negligible phenotype may appear of little significance, by carrying a certain allele, other 
rearrangements in the same genomic region can be predisposed, which in turn could lead to disease. 
In these cases, the parents of affected individuals would show a higher frequency of one of the 
inversion alleles compared with the general population (Puig et al. 2015b). For example, direct 
association between an inversion carrier status, including common polymorphic variants, and 
increased risk for deletions in the offspring has been established in several microdeletion syndromes 
(Feuk 2010). Nonetheless, the probability for an inversion carrier to predispose a child to other 
rearrangements is still extremely low (Puig et al. 2015b). 
 
Aside from the recognized problems that hinders rearrangements detection and the analysis of their 
impact, the knowledge on the contribution of structural variants to disease is possibly being 
underestimated owing to the use of exome sequencing to identify causal genes: this sensitive method 
fails to detect genes truncated by breakpoints (Puig et al. 2015b). 
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1.5. Identification of Chromosomal Anomalies 
 
1.5.1. Conventional Technologies 
 
Classical study of chromosomes has been based primarily on large-scale rearrangements via 
karyotype analysis with classical G-banding techniques (Alves et al. 2012). Only asymmetrical forms 
which give rise to acentric fragments or extensive alterations across several chromosomal bands are 
readily visible (Obe et al. 2002), and even significantly larger rearrangements may escape detection if 
the affected segments lead to little difference in the banding pattern. Chromosomal aberrations 
detected through these methods are of very low resolution, in the magnitude of 5 to 10 Mb, aside from 
being laborious and not permitting a global unbiased discovery (Feuk 2010). 
 
As consequence, subsequent fluorescence in-situ hybridization (FISH) mapping across the 
breakpoints was used for a more detailed delineation of these events (Utami et al. 2014), with 
resolution between 200kb and 2MB depending on the type of FISH used. Also, with the aid of 
differential fluorochrome mixes, it is possible to digitally “paint” the chromosomes (pseudocolor) and 
thus follow the exchange of segments between them. However, it generally is not applied to 
inversions nor other alterations within the same chromosome as the kits usually “paint” each 
chromosome with one color (Obe et al. 2002).  
 
Similarly, bacterial artificial chromosomes spanning the chromosome breakpoint can be used for 
segregation pattern analysis (Bhatt et al. 2007). For inversions larger than 2 Mb, inversion breakpoints 
can be mapped by metaphase FISH using two probes located more than 2 Mb apart inside the inverted 
region. Smaller inversions of down to 200 kb can be resolved by three-color interphase FISH. Still, it 
is difficult to correctly assess the probes relative position, especially when breakpoints map to 
duplicated sequences (Antonacci et al. 2009), aside from remaining target-based (Alves et al. 2012). 
 
More recently, array comparative genome hybridization (array CGH) was developed. These genomic 
microarrays with high density of SNP markers are extremely capable in the identification of copy 
number changes or imbalances genome-wide at a relatively high resolution, being conventionally used 
for the detection of duplications or deletions as well as loss of heterozygosity (Feuk 2010). Actually, 
nowadays, it is one of the preferred clinical diagnostic tests to detect anomalies in prenatal diagnosis, 
when one or more major structural abnormalities were identified in a fetus by ultrasonograph (Ordulu 
et al. 2016) or for individuals with multiple congenital anomalies and developmental delays (Leonard 
2016). However, this method fail to identify copy number neutral rearrangements like inversions 
because they are unable to determine genomic positions, only of copy number state (Utami et al. 
2014), and are prone to artifacts like calling of false positives or high background noise (Alves et al. 
2012; Curtis et al. 2009). 
 
The characterization of structural variants are indeed often stalled by technical challenges in genome-
wide screening (Pinto et al. 2007). Detection and analysis of rearrangements with low resolution 
technologies can be difficult or inconclusive (Obe et al. 2002). Additionally, evidence show that 
repeated sequences are common at rearrangements breakpoints, making characterization by standard 
molecular approaches even more challenging (Antonacci et al. 2009).  
 
Since conventional cytogenetic often overlooks complex anomalies, higher resolution platforms must 
be called into action (Gregori et al. 2007). 
11 
1.5.2. The advent of Next-Gen Technologies 
 
1.5.2.1. Sanger Sequencing 
 
The era of “first-generation sequencing” started with Sanger sequencing. Since its conception in 1975, 
by Edward Sanger, it has been used extensively and is nowadays still regarded as the gold standard 
for the determination of nucleotide sequences (Grada and Weinbrecht 2013). Among its many notable 
achievements, it permitted the demystification of previously believed to be near-impossible feats, 
such as the sequencing of an entire complex genome, the Human Genome Project, completed in 2003 
(Metzker 2010). 
 
There are two technical approaches in Sanger sequencing, depending on whether it is a de novo 
sequencing or a resequencing. In the first case, DNA is randomly fragmented, cloned into a plasmid 
then used to transform Escherichia coli; in the second, a PCR amplification is performed. The 
sequencing takes place during cycles of template denaturation, primer annealing and extension. 
During extension, a fluorescently labeled dideoxynucleotides (dNTP) is incorporated then 
stochastically terminated. Inside a capillary based polymer gel, laser excitation of end-labels permits 
the identification of the nucleotide identity based on its signal. Software translates the signal and 
generates chromatogram. Sanger sequencing can reach read-length up to of around 1000 bp with over 
99.9% accuracy (Shendure and Ji 2008). 
 
 
1.5.2.2. Next-Generation Sequencing 
 
The demand for the development of cheaper and faster sequencing to generate large amounts of data 
has increased greatly over the years, driving the development of new technologies. Subsequently, in 
recent years, there was a slow yet steady shift away from Sanger sequencing - the time of the “second-
generation”, also known as Next-Generation Sequencing (NGS), has arrived (Metzker 2010).  
 
The major advance offered by NGS is the ability to produce an enormous volume of data in a 
relatively short amount of time (Metzker 2010). While NGS is still indeed expensive, novel 
approaches and refinements of existing methods are reducing the cost per base while increasing the 
throughput, easing the elucidation of variations not covered by other methods. Furthermore, the cost 
per base is significantly lower when compared to Sanger sequencing, due the sheer amount of bases 
identified at once. This capacity of sequencing many millions or billions of bases in hours is 
something that Sanger sequencing cannot even come close to match at its current form (Pettersson et 
al. 2009). 
 
Many studies have already ventured into this new promising land. Those that applied NGS-based 
methodologies into their work commend for its usefulness and effective ability to provide a vast 
amount of information, with an incredibly fine detail and a consistent validation rate, enabling the 
identification of the causal gene for many rare Mendelian disorders (Hanscom and Talkowski 2014; 
Talkowski et al. 2011; Utami et al. 2014; Vergult et al. 2014).  
 
Different NGS platforms coexist in the marketplace, each having specific advantages and 
disadvantages for particular applications (Metzker 2009). This has made sequencing accessible to 
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more laboratories, rapidly increasing the amount of research and clinical diagnostics being performed 
(Grada and Weinbrecht 2013).  
 
Every NGS platform embodies a complex interplay of chemistry, hardware and software engineering, 
allowing a highly streamlined sample preparation steps prior to DNA sequencing (Mardis 2008). 
Having been developed by different manufacturers, each platform use propriety methods that slightly 
differs from one other, with Illumina’s currently being the most widely used (Metzker 2010). 
Nonetheless, they share similarity in how the nuclear workflow is performed.  
 
The overall NGS methodology include template preparation, sequencing and imaging and, finally, 
data analysis (Grada and Weinbrecht 2013). Template preparation consists of building a library of 
nucleic acids. This is accomplished by random fragmentation of DNA, followed by a ligation of 
adaptor sequences and finally amplification of the library in preparation for sequencing (Mardis 2008; 
Shendure and Ji 2008). The sequencing process itself consists of alternating cycles of enzyme-driven 
biochemistry and imaging-based data acquisition. Most widely used platforms rely on sequencing by 
synthesis, in which the library fragments acts as template. The sequencing occurs through a cycle of 
washing and sequential flooding of the fragments with known nucleotides. As nucleotides incorporate 
into the growing DNA strand, they are detected and recorded sequentially (Grada and Weinbrecht 
2013). The captured signal is then analyzed with bioinformatics tools, where the obtained sequences 
are aligned to a known reference sequence (Metzker 2010). In sum, these technologies have the 
advantages of in vitro construction of a sequencing library, followed by in vitro amplification to 
generate sequencing features (Shendure and Ji 2008). 
 
The most comprehensive application of NGS may be the resequencing of human genomes to enhance 
our understanding of how genetic differences affect health and disease (Metzker 2010). Various 
studies have described the use of whole-genome sequencing to identify genomic breakpoints of 
chromosomal rearrangements at nucleotide resolution, facilitating candidate genes identification 
(Kloosterman and Hochstenbach 2014; Utami et al. 2014; Vergult et al. 2014).  
 
 
1.5.2.3. Mate-pair sequencing  
 
To define rearrangement breakpoints, studies have increasingly resorted to paired-end sequencing 
libraries. Introduced in 2007, it has since been used to identify more than a thousand structural 
variations in the human genome at unprecedented resolution. It involves the mapping of pairs of 
sequence reads to a reference genome, derived from the two ends of a single DNA segment 
(Kloosterman and Hochstenbach 2014). 
 
A major breakthrough in the discovery of structural rearrangements came in the form of mate-pair 
sequencing, a type of paired-end sequencing which resorts to larger segments of 2 to 6 kb between 
each read pair (Talkowski et al. 2011; Utami et al. 2014; Vergult et al. 2014). With reads so far apart, 
mate-pair sequencing is able to cover difficult DNA sequence features such as repetitive regions. 
These libraries are particularly useful for the analysis of inversions, since the presence of inverted 
reads at breakpoints hinder their identification using single reads or paired-end sequencing of shorter 
fragment size (Aguado et al. 2014). Many of the predicted inversions so far have used this strategy 
(Puig et al. 2015b). Furthermore, Hillmer and colleagues (2011) have demonstrated that large insert 
fragment sizes provided higher physical coverage with minimum sequencing efforts.  
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Large-insert library preparation proposed by Talkowski and collaborators (2011) is a type of library 
prepared for whole-genome mate-pair sequencing. It is a customized library preparation optimized for 
structural rearrangements. It is also generally less expensive than commercially available 
counterparts. The main construction steps of this mate-pair library are schematized in Figure 1.2., 





Figure 1.2 Large-insert library preparation for NGS, as described by Talkowski et al (2011). 
A) Genomic DNA sheared using an ultrasonicator to a mean size of 3 kb. 
B) Cap adaptors containing a EcoP15I recognition site are ligated 
C) DNA size-selection of fragments of between 2.5 and 6 kb 
D) Circularization of DNA with biotinylated adapters 
E) DNase treatment to remove linear DNA, then digestion with EcoP15I restriction enzyme on the circularized DNA  
F) DNA fragments bind to streptavidin beads, and dA tailing 
G) Ligation of barcoded adapters with Illumina specific indexes enables multiplex during sequencing; dots indicates where 
the oligos anneal 
H) PCR enrichment of the library, dots indicating annealing of primers and arrows the direction of extension during PCR 
I) Final library molecule of around 200 bp, ready for sequencing.      
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1.5.2.4. Analysis of sequencing data 
 
After obtaining the final library fragments, the ends are sequenced in a massive and highly parallel 
manner. The resulting reads then mapped to a reference genome. The majority of the read pairs would 
map concordantly to a reference genome, as expected. However, if the read pairs do not map 
concordantly, in other words, if a cluster of several read pair maps to highly distant sites or with an 
unexpected orientation, then it points to the existence of a structural rearrangement in between. 
Abnormal location and orientation mappings of the read pairs are indicative of the presence of an 
inversion breakpoint (Feuk 2010; Puig et al. 2015b; Utami et al. 2014), as illustrated in Figure 1.3.. 
Furthermore, identification of split read mapping gives insight into the precise breakpoint junction 
sequence (Kloosterman and Hochstenbach 2014).  
 
This technology is capable in identifying rearrangement breakpoints at nucleotide level. Generally, 
however, while the depth of coverage is in average 60x, it varies highly from region to region. In 
locations where the average is low, it may not be enough for the identification of structural 
chromosomal anomalies with a nucleotide resolution. Thus, it usually predicts breakpoint coordinates 





Figure 1.3. Inversion breakpoints discovery using mate-pair sequencing and mapping (adapted from Feuk 2010). 
Lines in red show fragments spanning into the inversion while blue are the normal unaltered fragments, with the boxes being 
read-pairs. Orientation of reads that map concordantly to reference genome is indicated by “+”, otherwise by “-“. When the 
pairs align to the reference genome, the majority map in a +/- orientation (A and D), since they are in a region without any 
structural alteration. In the region containing an inversion, the breakpoints would map as +/+ and -/-, respectively (B and C). 
 
 
In the end, while this approach is appealing because it is validated in fine-mapping structural 
breakpoint and for interrogation of structural polymorphisms, it still cannot be used as the sole 
methodology. For example, it is very challenging to distinguish an identified inversion breakpoints 
from duplications that reinserted in an inverted orientation (Corbett-Detig et al. 2012). Additionally, 
as mate-pair sequencing heavily relies on the reference assembly, very rare or unique alleles and any 
mis-assembly are serious challenges to overcome. The small size of the library fragments may be 
problematic for alignment to regions with high identity SD or with repetitive sequences (Feuk 2010; 
Rasekh et al. 2015).  
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In other words, although sequencing technologies have certainly proven their worth as the most 
efficient methods in chromosomal rearrangements screening and breakpoint identification, 
overlapping various methodologies remains the best practice worldwide (Ordulu et al. 2016). With a 






The principal objective of the present study is the identification of molecular alterations and of 
candidate genes responsible for a malformation syndrome in an individual with an apparently 
balanced maternally inherited pericentric chromosome inversion inv(2)(p16.1;q14.3)mat. More 
specifically, the goals involve: 
 Identification of inversion breakpoints with nucleotide resolution 
 Characterization of the inversion breakpoint regions  
 Clarification on the role played by the detected inversion in the malformation syndrome  
 Investigate existence of other chromosomal structural anomalies 
 Conduct familial segregation analysis on additional family members 





2. MATERIALS AND METHODS 
 
2.1. Sample Preparation 
 
2.1.1. Biological samples 
 
Peripheral whole blood from the proband and his mother were collected in 2007 after informed 
consent. The blood was stored in specialized collection tubes containing ethylenediamine tetraacetic 
acid (EDTA) for downstream genomic DNA extraction, and in collection tubes with heparin sodium 
for establishment of cell lines.  
 
In 2017, additional biological samples were obtained. Peripheral whole blood from the proband, his 
mother and his father were collected. 
 
 
2.1.2. Cell culture 
 
Lymphoblastoid cell lines (LCL) are commonly used as source of difficult to obtain biological 
material. The somatic mutation rate of LCLs is estimated to be 0.3%. Additionally, the relative ease of 
cell maintenance makes them an attractive alternative of genetic material source (Sie et al. 2009).  
 
Cell culture procedures were done in accordance to the described in the papers published by David et 
al. (2009; 2013). 
 
The LCL from the proband was placed in culture for the continuation of this case study. The cells 
were maintained in complete cell medium developed for suspension cells. The cell medium was 
prepared as follow: Roswell Park Memorial Institute medium (Gibco), 15% heat inactivated fetal 
bovine serum (FBS-Hi) (Gibco), 1% glutamine and 1.5% of Penicillin-Streptomycin. The LCL was in 
a constant temperature of 37ºC, in an incubator with dioxide carbon levels at 5%. Every two days, the 
LCL was observed to confirm their health and growth. The cells were counted often to maintain 
optimal cell concentration. Trypan blue were used to selectively staining dead cells. A Neubauer 
chamber was used and cells counted under a microscope, where only live (non-stained) cells were 
considered. An ideal concentration would be around 0.7x106 cells per ml, generally in 10 ml of cell 
medium, for a total cell count of 0.7x107. 
 
 
2.1.2.1. Cryogenic preservation of LCL 
 
The LCL were cryogenically preserved in liquid nitrogen (-170ºC) as to retain a backup of biological 
sample. The viability cells greatly depends on how well the process underwent. If the procedure was 
not done with care, the cells may take a long time to recover or even die off (Withers and Street 
1977). In brief, the cells were transferred to a cryovial in a cold freezing medium prepared with 90% 
FBS-Hi and 10% dimethyl sulfoxide. The tubes were kept 24 hours at -80ºC in a cryobox filled with 
isopropanol, allowing for a constant rate of temperature drop (1ºC/min). Afterward, they were stored 
in a container with liquid nitrogen. 
 
18 
2.1.2.2. Cells pellet preparation for DNA and RNA extraction 
 
For the purpose of DNA and RNA extraction from LCL, dry cell pellets were prepared. Briefly, the 
entire culture volume was transferred into a 15 ml centrifuge tube, centrifuged and washed twice, then 
transferred to a 2ml microcentrifuge tube and centrifuged once again. The cell pellet was air dried, 
then stored at -20ºC.   
 
 
2.1.3. DNA extraction for peripheral blood and LCL 
 
Genomic DNA from peripheral blood samples was extracted using the QIAamp Midi DNA Blood kit 
(QIAGEN). It was designed for the extraction and purification of genomic DNA up to 50 kb from 




In brief, peripheral blood was incubated at room temperature for 2 hours. Proteinase K (PK) and 
Buffer AL was added to 1.2 ml of blood, then vigorous mixed and incubated at 65ºC for 30 minutes to 
promote cell lysis. The DNA were precipitated with molecular biology grade absolute ethanol. Wash 
buffers AW1 and AW2 removed traces of contaminants like proteins aided by a series of 
centrifugations. The DNA was then eluted in low TE buffer (10mM Tris pH7.5, 0.1mM EDTA), 
which minimizes the risk of downstream enzymatic reactions inhibition due to EDTA and DNA 
degradation of elution in pure water. 
 
The Blood & Cell Culture DNA Midi kit (QIAGEN) was used for the extraction of genomic DNA 
from LCL, according to manufacturer’s instructions (QIAGEN Genomic DNA Handbook, http:// 
www.qiagen.com/ie/resources/resourcedetail?id=402bb209-4104-4956-a005-6226ff0b67d5). This kit 
is suitable for the extraction of high molecular weight genomic DNA of up to 150 kb, with the 
downside of being a long and laborious process.  
 
In summary, 2x107 LCL cells, dry pelleted as described above, was resuspended. Buffer C1 and ice-
cold water was used to lyse the cells, keeping the nucleus intact. Nucleus disruption and protein 
denaturation were promoted by Buffer G2 and PK with an incubation at 50ºC for 1 hour. The DNA 
then were bound to the column while other cell constituents gently passed through by gravity flow, 
followed by several wash steps to remove any remaining contaminants. The purified DNA was eluted 
in Buffer QF (1.25 M NaCl, 50 mM Tris·Cl pH 8.5, 15% isopropanol). 
 
The extracted DNA was quantified with Nanodrop ND-1000 spectrophotometer (ThermoFisher), 
using the corresponding elution buffer as blank, according to manufacturer’s instructions (NanoDrop 
1000 Spectrophotometer V3.8 User’s Manual, http://www.nanodrop.com/Library/nd-1000-v3.8-users-
manual-8%205x11.pdf). The DNA quality was accessed with the absorbance ratios A260/A280 and 
A260/230, where a value of 1.8 and 2.0, respectively, indicates a sample free of contaminants such as 
phenol and proteins. Note that spectrophotometers detects a variety of nucleic acids, so if a DNA 




To confirm the quality control with Nanodrop, as well as to check the integrity of the DNA, agarose 
gel electrophoresis was used. Lambda DNA/HindIII marker was used as both quantity and molecular 
weight reference. As such, 100 ng and 200 ng of Lambda DNA/HindIII and DNA samples were 
loaded into a 0.8% agarose gel in TAE buffer and ethidium bromide, and ran for 3 hours at 45 V. A 
high quality DNA would appear as a high molecular weight and distinct band with little to no smear. 
Quantity-wise, it can be inferred by comparing the band intensity of the DNA and the marker’s – the 
quantity would be similar if the intensity is nearly the same.  
 
 
2.1.4. RNA extraction from LCL 
 
The LCL was harvested as described above. Total RNA extracted with QIAamp RNA Blood Mini Kit 
(QIAGEN), in accordance to the manufacturer’s indications (QIAamp RNA Blood Mini Handbook, 
http://www.qiagen.com/us/resources/resourcedetail?id=5ea61358-614f-4b25-b4a5-a6a715f9d3aa).  
 
In brief, 0.8x107 cells were resuspended and disrupted with Buffer RTL, beta-mercaptoethanol added 
to reduce RNase activity, and then the lysate transferred to a shedding column. The freed RNA was 
precipitated with molecular grade absolute ethanol and bound to a column membrane. 
Deoxyribonuclease I was added to remove any existing DNA molecule, and sequential washes 
removed remaining cell debris and other contaminants. The RNA was eluted in the provided nuclease-
free water and quickly stored at -80ºC. 
 
The extracted RNA was immediately quantified with a Nanodrop ND-1000 spectrophotometer 
(ThermoFisher), using nuclease-free water as blank, according to manufacturer’s instructions. The 
absorbance ratios A260/A280 and A260/A230 must fall between 1.8 and 2.0 to be considered “pure” 
samples free of significant contaminants. 
 
A significantly more sensitive, albeit slower and more expensive, method of quality control of RNA 
samples is the use of 2100 Bioanalyzer (Agilent). This control was done by an external service 
provider. Agilent’s RNA 6000 Nano Kit was used, according to manufacturer’s instructions. Due to 




2.2. Polymerase Chain Reaction 
 
2.2.1. Primers Design 
 
Sequencing results from NGS allowed for the determination of the chromosome 2 inversion 
breakpoints, delimitating the region within which a breakpoint is located. As such, primers were 
designed on each side of this region, with the software OLIGO Primer Analysis and NCBI’s Primer-
BLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast). The first calculates free energy, 
hybridization temperature and nucleotides secondary structure (Rychlik and Rhoads 1989). The 
second designs primers specific to a PCR target, aligning them against a reference genome to 
minimize non-specific amplifications (Ye et al. 2012). 
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In order to increase the probability of obtaining a high quality primer, candidate primers had to be 
confirmed to be in the correct position and have their specificity checked using BLAST against 
human reference genome. Furthermore, primers located in highly repetitive regions were avoided 
whenever possible. Of the possible primers for each side of the breakpoint region, the one that had the 
lowest score for dimer formation and self-complementarity, given by OLIGO software, was chosen 
(Table 2.1.). The primers were synthesized by an external provider. 
 
 
Table 2.1. Primers for the chromosome 2 inversion. 





























a Numbers indicate the position of primers in the human genome assembly GRCh37. 
b Annealing temperature given by OLIGO software. 
 
 
2.2.2. Amplification of DNA by PCR 
 
The inversion breakpoint junction fragments were amplified by polymerase chain reaction (PCR), 
using the designed primers, to determine the breakpoints’ genomic position.  
 
For chromosomal inversions, each pair of primers used for amplification of junction fragment is of the 
same orientation (i.e. primers forward with forward, reverse with reverse), as it is composed by a 
union of inverted and non-inverted sequences. The breakpoint at inv2p16.1 used primers AC015982-
1F (as forward) and AC096744-3F (as reverse), while the breakpoint at inv2q14.3 used primers 
AC015982-2R (as forward) and AC096744-4R (as reverse), as described in Table 2.1..  
 
For the PCR reaction 50 µl of mixture was used. The master mix was prepared as follow: per reaction, 
50 µl of in-house premix (20 µl dNTP 100 mM; 1 ml GeneAmp 10X PCR Buffer I (Applied 
Biosystems); 9 ml water treated with diethylpyrocarbonate (Bioline), 0.5 µl of forward primer (300 
ng/µl), 0.5 µl of reverse primer (300 ng/µl) and 0.5 µl of AmpliTaq DNA Polymerase (Applied 
Biosystems). Afterwards, 50 µl of master mix was transferred into 200 µl thin-walled microcentrifuge 
tubes then, finally, 100 ng of genomic DNA was added, except for the negative controls. 
 
The amplification was performed in a thermalcycler (Biometra), with the following setup: an initial 
denaturation of the DNA at 94ºC for 3 minutes, followed by 35 cycles of a 45 seconds long 
denaturation step at 94ºC to create single-stranded templates, 40 seconds of primers annealing to the 
templates at 63ºC for the inv2p16.1 breakpoint and 61ºC for the inv2q14.3 breakpoint, and an 
extension at 72ºC for 75 seconds. Afterwards, a 3 minutes final extension guaranteed that the DNA 
molecules had enough time to be synthesized and all single-stranded DNA was fully extended. The 
reaction was then cooled down to 4ºC to avoid degradation to due extended exposure to heat.  
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2.2.3. Quality control of PCR products 
 
PCR amplification success was confirmed by standard horizontal agarose gel electrophoresis. For 
that, 5 µl of PCR product was mixed with in-house orange-G loading buffer, then transferred to a 
1.2% agarose gel in TAE buffer 1x. For molecular weight marker, Hyperladder 50 bp (Bioline) was 
used. The electrophoresis ran for 90 minutes at 50 V.  
 
If the amplification proceeded with sufficient efficiency, then a distinct high intensity band within the 
expected size range would be seen. And if the primers were specific enough for the sequence of 
interest, no other bands aside from the high intensity band would appear on the gel. 
 
 
2.2.4. Purification of PCR products 
 
The PCR products amplified successfully were purified with Amicon Ultra-0.5 ml Centrifugal Filters 
(Millipore), following the manufacturer’s instructions (Amicon Ultra-0.5 Centrifugal Filter Devices 
User Guide). This kit is designed for the removal of small nucleic acids like primers and unused 
dNTP, as well as enzymes and salts. Filters in the column retain higher molecular weight DNA while 
the contaminants flow through it by centrifugation. By diluting the PCR product with low TE buffer 
to the maximum volume of 500 µl, it increased the efficiency of contaminants removal. The sample 
recovery was done with centrifugal force by inverting the column into a clean microcentrifuge tube. 
 
The purified sample was quantified with Nanodrop ND-1000 spectrophotometer (ThermoFisher), 
according to manufacturer’s instructions. 
 
 
2.3. Sanger Sequencing 
 
Sanger sequencing The ABI PRISM BigDye Terminator Cycle Sequencing Kit (Applied Biosystems) 
was used to prepare the DNA samples for sequencing.  
 
For that, the sequencing reaction was prepared by mixing 3 µl of Sequencing Buffer and 2 µl of Big 
Dye then 40 ng of the previously purified and quantified PCR product was added, followed by 1 µl of 
one of the primers (10 ng/µl) for that fragment, either forward or reverse, is used in one reaction – in 
other words, each PCR product was sequenced twice, each with a different primer used in the original 
PCR amplification. Finally, nuclease-free water was added to bring the total volume to 20 µl. The 
reaction was then conducted in a thermalcycler as following: a denaturation step at 96ºC for 10 
seconds, an annealing step at 61ºC for the inv2p16.1 fragment and 59ºC for the inv2q14.3 fragment 
(2ºC lower than at PCR amplification) for 5 seconds and an extension step at 60ºC for 4 seconds. A 
final extension was performed also at 60ºC, for 3 minutes. The reaction was then put on hold at 4ºC. 
 
The Sanger sequencing was performed by an external service provider, on an ABI PRISM automatic 
sequencer (Applied Biosystems). The results were returned in form of chromatograms, which were 
read against the reference genome. A breakpoint is found when the sequenced fragment stops 
matching the reference sequence. Also, any other small alterations, such as SNPs or microdeletions, 
are recorded and investigated on public databases.  
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2.4. Genomic Array 
 
Genomic DNA from the proband and his parents were analyzed by high-resolution CytoScan HD 
array from Affymetrix. This array excels in the identification of CNV, such as duplications and 
deletions, as well and other changes like loss of heterozygosity, and 96% of known genes are 
represented (Uddin et al. 2014). The assay was performed according to the CytoScan HD assay user 
manual (http://tools.thermofisher.com/content/sfs/manuals/cytoscan_assay_user_manual.pdf). Figure 







Figure 2.1. Overview of the CytoScan HD protocol (adapted from CytoScan Assay User Manual). 
The various stages for the preparation of array CGH. DNA is digested, ligated to adapters then amplified by PCR. The 
products are purified, fragmented and labelled before overnight hybridization on an array. A wash and stain process prepares 






Briefly, 250 ng of genomic DNA from peripheral blood was digested with restriction enzyme NspI 
and ligated to an adapter, followed by PCR amplification in 4 tubes with primers that specifically 
anneal to the adapter sequence. The PCR products were controlled on a 2% agarose gel in TBE 
buffer; the expected size ranges between 150 and 2000 bp in length. The tubes from each sample were 
pooled and purified with magnetic beads to remove contaminants from the PCR reaction. The purified 
DNA was fragmented using DNase I and visualized on a 4% agarose gel in TBE buffer. This step is 
the most critical of all and the fragments must be within 25 and 125 bp. The fragments were then 
labelled with biotin and hybridized overnight at 55ºC and 60 rpm to a CytoScan GeneChip array. The 
arrays were washed and stained on a GeneChip Fluidics Station 450, and scanned with a GeneChip 
Scanner 3000 7G, both from Affymetrix.  
 
Raw data files were generated using the software GeneChip Command Console. The data was 
analyzed with the Chromosome Analysis Suite software version 3.1 and NetAffy genomic annotation 
file version 33.1 (GRCh37), both developed by Affymetrix. Alterations were queried in the Database 
of Genomic Variants (DGV) to check for potential common rearrangements, and genes inside or 
flanking alterations were checked at the OMIM database. 
 
Only CNV of at least 100 kb and with at least 30 supporting probes were considered of interest, as to 
avoid high level of background noise and false positives for smaller variations with a small number of 
supporting probes. Nonetheless, CNV of at least 50 kb were checked to confirm whether they affected 
OMIM genes reported to be related to the proband’s clinical phenotype. 
 
 
2.5. Expression Array 
 
Gene expression in the proband was analyzed using Affymetrix Human Transcriptome 2.0 (HTA 2.0) 
GeneChip array. This expression array is considered one of the most accurate and extensive tool in the 
detection of currently known transcript isoforms produced by human genes.  
 
The protocol was implemented in the research group and performed in accordance to the 
manufacturer’s guidelines (GeneChip WT Plus Reagent Kit Manual Target Preparation for GeneChip 
Whole Transcript Expression Arrays User Manual, http://tools.thermofisher.com/content/sfs/manuals/ 
wtplus_reagentkit_assay_manual.pdf). Figure 2.2. summarizes the procedure, up until the 
hybridization of samples to the Genechip arrays. 
 
Briefly, 100 ng of total RNA extracted from LCL established from the proband was processed with 
reagents from WT PLUS reagent kit (Affymetrix) as indicated by manufacturer’s protocol. Total 
RNA was first mixed with Poly-A RNA positive controls. A series of synthesis and purifications are 
performed, starting with the input RNA until sense-strand cDNA is obtained by the reverse 
transcription. This cDNA was labelled before an overnight hybridization at 45ºC to a Human 
Transcriptome 2.0 GeneChip array (Affymetrix). The end goal is to prime the entire length of RNA to 
provide complete and unbiased coverage of the transcriptome. Hybridized arrays were washed and 
stained then scanned following the manufacturer's instructions, using GeneChip Fluidics Station 









Figure 2.2. Overview of the Affymetrix Human Transcriptome Assay 2.0 protocol (adapted from GeneChip WT PLUS 
Reagent Kit user guide).  
The various stages for the preparation of gene expression array. Synthesis of cDNA from total RNA, followed by cRNA 
amplification and purification. A second round of cDNA is synthesized, purified and quantified. It is then fragmented and 
labelled before overnight hybridization on an array. Wash, stain and scanning processes are not here pictured. 
 
 
The raw data generated were processed in Affymetrix Expression Console software using the RMA 
algorithm for normalization, background correction and signal summarization. Afterwards, the 
software Affymetrix Transcriptome Analysis Console was used to identify and compare gene 
expression levels.  
 
The control group consisted of RNA samples from LCL of unrelated individuals without any of the 
alterations found in the proband. The control group was analyzed with Affymetrix HTA 2.0, 
following the protocol described above. Additionally, a set of 12 control individuals considered of 
normal phenotype on Affymetrix Human Gene 1.0 ST expression array was obtained from a publicly 
available GEO dataset (GSE42816, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE42816). 
This would give a broader on how variable the expression of certain genes are, independent of the 




2.6. Web Resources 
 
Publicly available databases and online resources on genomic data were frequently queried during the 
development of this thesis. The web resources are the following: 
 
UCSC Genome Browser (http://genome.ucsc.edu) and Ensembl (http://www.ensembl.org) offered 
general and also positional information on genetic elements of interest (e.g. genes, regulatory 
elements, repeated regions, SD);  
 
NCBI’s dbVar (http://www.ncbi.nlm.nih.gov/dbvar) and the Database of Genomic Variants (DGV, 
http://dgv.tcag.ca/dgv/app/home) were used to check for reported structural variants; 
 
InFest (http://invfestdb.uab.cat) served as hub of reported chromosomal inversion polymorphisms; 
Gene Card (http://www.genecards.org) was used for information on genes of interest, namely of those 
flanking breakpoints; 
 
Mouse Genome Informatics (http://www.informatics.jax.org) and the Genotype-Tissue Expression 
Project (http://www.gtexportal.org) were used for gene expression data in mouse models;  
 
Database of Genomic Variation and Phenotype in Humans using Ensembl Resources (DECIPHER; 
http://decipher.sanger.ac.uk/) aided the interpretation of genomic variants; 
 
Online Mendelian Inheritance in Man (OMIM, http://www.omim.org) was central for identifying 





3. RESULTS AND DISCUSSION 
 
3.1. Clinical report 
 
The proband is male, child of non-consanguineous parents. The parents are both healthy and 
apparently phenotypically normal. A paternal uncle died at age 5 of unknown causes. 
 
The pregnancy underwent without any complications. However, in the 3rd trimester ultrasound, 
evidence of delayed intrauterine development was found. Delivery occurred at 41st week of gestation. 
At birth the proband showed very low birth weight (P5) and length (<P5). Generalized hypertonia and 
feeding difficulties were described. 
 
Severe congenital malformation syndromes became more apparent as the proband grew up.  
 
At 2 years of age, cryptorchidism with hydrocele was corrected. He took his first steps when he was 3 
years old. At 7 years old, the proband presented severe global psychomotor developmental delay and 
congenital microcephaly was reported. He has facial dysmorphism, with a triangular face, hollow eyes 
and thin upper lip. He was hospitalized due to intestinal volvulus in the same year.  
 
The timing of basic competences acquisition was very late. He did not develop speech but is able to 
understand very simple orders and sentences. Autism spectrum disorder (ASD) was diagnosed at 
infancy, and he is being medicated ever since. He shows stereotypical ASD features such as 
hyperactivity, attention deficit and can become easily impatient. He has mouthing habits, often 
bringing foreign objects into his mouth and swallowing them. Feeding difficulties continued through 
childhood. He suffers from severe chronic constipation, being medicated daily. 
 
Atrial septal defects with interatrial communication (ostium secundum type) was detected and later 
surgically corrected at 9 years of age. At 15 years old, he still has generalized muscle hypertonia with 
symmetric myotonic hyperreflexia, being able to mobilize all four limbs without asymmetry. Wide-
based gait is noticeable. He has scoliosis with left-side concavity. He has bilateral nail dysplasia and 
bilateral overlapping of the hallux over the second toe. 
 
Craniocerebral magnetic resonance done during the first year of age showed no relevant alterations. 
Metabolic analysis performed when he was 15 years old reported normal results for his gender and 
age group.  
 
Currently, at 16 years of age, he is of short stature (p10) and of very low weight (p<5). He remains 
completely dependent of aid in all activities of daily life. 
 
 
3.2. Cytogenetic studies 
 
The pedigree of proband’s family is shown in Figure 3.1.. 
 
Classical cytogenetic analysis of GLT-banded chromosomes revealed an apparently balanced 
pericentric inversion at the chromosome 2 in the proband (III:1). More precisely, the inversion 
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breakpoints were found to be situated at cytobands 2p21 and 2q21. The total number of chromosomes 
per cell was normal. The subject’s karyotype was described as 46, XY, inv(2)(p21q21.1)mat. 
 
Cytogenetic studies were also performed on family members, namely his father and mother (II:3 and 
II:4). In the mother, a pericentric chromosome 2 inversion, inv(2)(p21q21.1) was found, suggesting 
that the inversion at chromosome 2 in the proband is of maternal origin. The father harbors a 






Figure 3.1. Pedigree of the proband’s family.  
The proband with the inv(2)(p21q21.1)mat, associated with severe congenital malformation syndromes and severe global 
psychomotor developmental delay, is depicted by a black square (      ) and indicated by an arrow. The mother, carrier of an 
inv(2)(p21q21.1), is depicted by a circle with vertical lines (    ). The proband’s father and paternal grandmother, both 
carriers of an inv(7)(p12.2q21.12), are depicted by horizontal lines filling a square (       ) and a circle (     ), respectively. The 




3.3. Imbalanced structural alterations 
 
3.3.1. Identification of imbalanced variations 
 
For the screening of imbalanced structural alterations in proband, high resolution genomic array 
Affymetrix’s CytoScan HD was performed. Genomic DNA extracted from whole blood was used. 
 
The genomic array detected several copy number variation in the proband. Most of these structural 
alterations detected in the proband were small (<100 kb) and located in intergenic regions. The 
identified variations that directly affected at least one gene often included no OMIM gene, have no 
phenotypical data available or were not described as associated with the observed clinical features.  
 
For the proband, chromosome structural variations of at least 100 kb in length and with at least 1 
reported OMIM gene are shown in Table 3.1.. In particular, a 590 kb duplication was found in 2q21.1, 
encompassing 13 protein-coding genes, 6 of which described in the OMIM database. The microarray 




Table 3.1. Major structural genomic imbalances in proband  
 a Numbers indicate the position of probes in the human genome assembly GRCh37. 
 
 
Since a possibly pathogenic large duplication is present in the proband, the parents were also analyzed 
by array CGH Affymetrix’s CytoScan HD, in order to understand the origin of the CNV. 
 
In the father, several small sized variations were also identified, most of them not affecting OMIM 
genes. Notably, a 610 kb duplication was found in chromosome 2 at q21.1. The duplication identified 
in the father is summarized in Table 3.2. 
 
 
Table 3.2. The 610 kb duplication in proband's father 




















































































































The vast majority of the imbalanced structural variations found in the mother are small and do not 
include any OMIM gene, thus unlikely to be pathogenic. 
 
The 590 kb duplication is further studied and described in the next section. 
 
 
3.3.2. Chromosome 2 duplication 
 
3.3.2.1. Characterization of the duplication 
 
Array CGH data from CytoScan HD revealed the presence of a large copy number gain in the long 
arm of chromosome 2, at q21.1. It is 589176 bp in length, located at genomic position 
chr2:130,569,840-131,159,016 (GRCh37) (Figure 3.2.), between starting marker C-7FBQG and end 
marker C-3ZABJ. The preceding marker is C-6VUDT and the following marker is C-6EDBO, located 
in g.130,569,860 and g.131,189,564, respectively. The mean distance between markers in this 





Figure 3.2. Comparative analysis of the 590 kb duplicated genomic region at 2q21.1.  
A) The 590 kb duplication at 2q21.1 in the proband. The blue box highlights the duplicated region, described as 
arr[GRCh37] 2q21.1(130,569,840-131,159,016)x4.  
B) The same region from the proband’s father. A 610 kb duplication was found, described as arr[GRCh37] 
2q21.1(130,575,123-131,184,830)x4.  
C) The same region from the proband’s mother. No variation in copy number state identified. 
Genomic positions are in genome reference assembly GRCh37. 
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The 610 kb copy number gain identified in proband’s father at 2q21.1 is shown in Figure 3.2.B. The 
2p21.1 duplication in father and son are very similar in regard to both location and size, differing only 
by a few markers in the extremities. Since the duplication in the father was interpreted by the software 
as being slightly bigger, it encompasses 14 genes. The pattern of copy number state variation within 
the duplication is also very similar between the two. No alteration in this region was detected in 
proband’s mother.  
 
The duplication is in a genomic region with multiple segmental duplications, copy number variations 
and repeats described in the literature (Figure 3.3). High similarity SD (> 96%) in the region are 
indicated in the figure. A cluster of SD is located inside the duplicated region, which is also flanked 
by another cluster at 3’. It is likely that they are linked to the presence of the duplication, since SD 
have long been considered rearrangements hotspots. However, it is unclear whether the segmental 




Figure 3.3. Genes, imbalanced variations and repeats in the duplicated genomic region at 2q21.1.  
A) Physical map across the duplicated region. Horizontal lines with folded grey arrows indicate the protein-coding genes in 
sense (above the map) and antisense (below the map) orientation.  
B) Clusters of segmental duplications in the region reported in the DGV database. Each blue bar is a segmental duplication 
with sequence identity between duplications of 96% or greater. The two clusters of segmental duplications are within the 
genomic locations indicated below (GRCh37).  
C) Clusters of CNV reported in the DGV database (blue are duplications, red are deletions, purple are regions of both gain 
and loss, grey are known variations of uncertain copy number state). 
D) Repeating elements in the duplicated region, such as interspersed repeats and low complexity DNA sequences, reported 
in UCSC Genome Browser. 
 
 
Variants in copy number are frequently described in this genomic region, be they of gain or loss. The 
DGV database reports 3 duplications of similar size that overlaps with the 590 kb duplication under 
study. A 412 kb duplication, located at chr2:130,837,924-131,250,371 (GRCh37) has a 10% overlap 
(Suktitipat et al. 2014). The 480 kb duplication described by Pinto et al. (2007) has 38% overlap and 
is located at genome position chr2:130,363,731-131,143,136 (GRCh37). Finally, a smaller duplication 
of 267 kb, located chr2:130,550,251-130,817,348 (GRCh37), has 61% overlap (Coe et al. 2014). 
These variations are all from healthy control samples. 
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Not indicated in DGV, the 374kb duplication reported by Schilter et al. (2013) is located at 
ch2:130,783,696-131,157,859 (GRCh37) with a 36% overlap with the 590 kb duplication. It is of 
uncertain pathogenic significance and is occasionally seen in control populations without detectable 
clinical phenotype.  
 
The presence of these CNV nearby the 590 kb duplication suggest that copy number gains in the 
region are probably neutral or at least sub-clinical in nature, if considering the variation alone. 
 
The fluctuation of copy number state seen in Figure 3.2. was likely exacerbated by noise related to 
artifacts in software interpretation of probe signals, possibly influenced by it being a SD rich region 
(Curtis et al. 2009). Additionally, the pattern could also be partially influenced by the distribution of 
repeated sequences, such as LINE and SINE, which could further exacerbate the variation of copy 
number state interpreted by the software. Therefore, the duplication was regarded as having an overall 
copy number state of x4, though this pattern was taken into consideration when analyzing any results 
related to the alteration, for example, in gene expression studies. 
 
 
3.3.2.2. Identification and characterization of genes from the duplicated region 
 
The duplication in the proband encompasses 13 protein-coding genes, 6 of which are found in the 
OMIM database (Table 3.3). Most of these genes are oncogenes or are of unknown functions.  
 
 
Table 3.3. Genes within the chromosome 2 duplication 
Gene Gene name Locationa  OMIM # 
RAB6C 




































IMP4, U3 Small Nucleolar 





Protein Tyrosine Phosphatase, Non-




a Numbers indicate the position of genes in the human genome assembly GRCh37. 
 
 
The only gene with clinical phenotype associated in OMIM is the Coiled-Coil Domain-Containing 
Protein 115 (CCDC115, chr2:131,095,814-131,099,922, GRCh37; OMIM *613734), also known as 
Coiled-Coil Protein 1 (CCP1). An autosomal recessive congenital disorder of glycosylation (CDG2O; 
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OMIM #616828) is associated with alteration in the gene (Jasen et al. 2016). It does not appear to be 
related to the proband’s observed phenotype. In mouse, CCDC115 is mostly expressed in the heart, 
liver, kidney, and testis, with lower expression in brain and lungs (Pellicano et al. 2006).  
 
Recently, another gene from this duplication was reported to result in pathology. The gene Tubulin 
Alpha 3E (TUBA3E; chr2:130,949,318-130,956,034, GRCh37), yet to be included in OMIM database, 
is a member of the tubulin family. Alterations in tubulin give rise to tubulinopathies, leading to 
complex cortical development malformations of varying severity (Bahi-Buisson et al. 2014). A case 
of tubulinopathy was reported as due to a punctual mutation in TUBA3E, with clinical features that 
includes the autosomal dominant microlissencephaly and global developmental delay (Alazami et al. 
2015). Since the cerebral magnetic resonance results found no notable alterations, the proband is 




3.3.2.3. Gene expression studies for the duplication 
 
Expression data from the transcriptome assay HTA 2.0 and HuGene 1.0 ST are shown in Table 3.4., 
for proband and control group known to not harbor the duplication. 
 
 
Table 3.4. Expression levels of the genes within the chromosome 2 duplication. 
Numbers indicate probe signal intensity 
 
 
The genes in the duplicated region do not appear to be differentially expressed when compared to the 
control group. Overall, the expression levels of these genes in the proband are relatively similar to the 
mean value of the control group, despite the existence of the duplication. This may be due to some 
degree of dosage compensation phenomenon (Kloosterman and Hochstenbach 2014).   
 
The haploinsufficiency index of a given gene denotes the predicted probability of an allele disruption 
being pathogenic, as it is unable to maintain normal function. A low score (<10%) indicates a high 
probability of a gene exhibiting haploinsufficiency, while a very low score (>90%) indicates genes 
likely to not exhibit haploinsufficiency (Huang et al. 2010). The scores of the genes within the 
Gene Proband C1 C2 C3 C4 C5 
Control HuGene 1.0 ST 
Mean SD  Mean SD 
LOC389033 3.46 4.92 4.91 5.04 4.88 3.46 4.64 0.66 - - 
RAB6C 3.16 4.15 4.71 4.71 4.34 3.16 4.21 0.64 - - 
POTEF 3.69 4.83 5.4 5.35 5.67 3.69 4.99 0.79 - - 
CCDC74B 4.03 5.31 5.45 5.55 6.25 4.03 5.32 0.81 - - 
SMPD4 7.76 9.32 8.35 8.22 8.93 7.73 8.51 0.62 7.25 0.20 
MZT2B 6.04 7.13 6.77 6.78 7.12 6.04 6.77 0.44 5.81 0.22 
TUBA3E 5.11 6.22 6.11 6.27 6.23 5.11 5.99 0.49 3.71 0.23 
CCDC115 4.87 5.78 5.42 5.64 5.76 4.62 5.44 0.48 6.81 0.19 
IMP4 9.19 9.16 8.32 8.81 8.83 8.87 8.80 0.30 9.35 0.24 
PTPN18 4.76 6.12 6.19 6.07 6.37 4.76 5.90 0.65 5.65 0.32 
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duplicated region is generally low, in average 77.5% with a minimum of 31% as indicated in 
Decipher database, suggesting that these genes are unlikely to be highly sensitive to copy number 
changes. 
 
It is of note that, because gene expression analysis was performed on total RNA extracted from LCL, 
the expression levels detected should be interpreted with a certain degree of caution, due to tissue-
specific mechanism in different cell types (Sie et al. 2009). In other words, the expression levels 
observed in LCL may be different to that of other tissue for some of the genes, even if biological 
samples from the same person and collected under the same conditions. Nonetheless, LCL are the 
most widely used tissue for these kind of studies, and was inclusively used in numerous extensive 
collections like the HapMap (Puig et al. 2015b). Hence, the expression results obtained here are sound 
for aiding the determination of potential candidate genes. 
 
There are several typical strategies for interpreting pathogenic or benign status for CNV (Miller et al. 
2010). For example, if a CNV is identical to one found in an apparently healthy parent or if no OMIM 
genes were linked to the phenotype, then it is likely a benign variation.  
 
The size and location of the 590 kb duplication in proband suggest that it is most likely the same 
variation as the 610 kb duplication in his father. It would mean that this duplication was paternally 
inherited. Since the father was considered phenotypically normal, this may indicate that the 
duplication is most likely non-pathological if considered as a single isolated alteration. 
 
As such, considering the available data, the 590 kb duplication by itself should be unrelated to the 
congenital malformation syndrome in the proband.  
 
Since imbalanced alterations were excluded as origin of the observed phenotype, whole-genome 




3.4. NGS library preparation and data analysis 
 
In order to determine the chromosome 2 inversion breakpoints, as well as to identify other balanced 
variations that may have been missed by previously used methods, large-insert whole-genome 
sequencing (liWGS) was performed. The large-insert libraries were prepared at Talkowski Laboratory 
at Harvard Medical School, following the protocol described in Talkowski et al. (2011). The library 
fragments were sequenced on a HiSeq 2000 sequencer (Illumina). The sequencing raw data was 
analyzed at Talkowski Laboratory and then in-house by the research group. 
 
No outstanding structural alteration aside from the already known chromosome 2 inversion was 








3.5. Characterization of chromosome 2 inversion 
 
3.5.1. Identification of the inversion breakpoints by NGS 
 
According to the NGS data, the chromosome 2 inversion breakpoints are located in 2p16.1 and in 
2q14.3 (Figure 3.4.). The inv2p16.1 breakpoint was localized between genomic positions 
g.55,934,646-55,935,223 (GRCh37) and the inv2q14.3 breakpoint between g.123,767,565-




Figure 3.4. Chromosome 2 ideograms.  




The breakpoint region at inv2p16.1 is supported by 14 read pairs, while inv2q14.3 was supported by 
12 read pairs (Figure 3.5.). Although none of the NGS reads mapped exactly on the inversion 
breakpoints, this approach allowed for a refining of their possible genomic locations into a small 
interval, delimited by pair reads that map across each of the inversion breakpoints. Consequently, it 
was possible to amplify these breakpoint regions by conventional PCR based on this information. 
Afterwards, identification of the exact breakpoints genomic location with a nucleotide resolution was 





Figure 3.5. NGS read pairs delimiting the inversion breakpoints.  
Read pairs delimiting the inversion breakpoints at inv2p16.1 and inv2q14.3, with possible location of breakpoint shaded 
blue. Black boxes are the reads, and the red arrows indicate their orientation compared to reference genome. 
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3.5.2. Amplification of inversion junction fragments 
 
The PCR amplification of the inversion breakpoint junction fragments and control fragments at 
inv2p16.1 and inv2q14.3 is shown in Figure 3.6.. As expected from a maternally inherited alteration, 
the junction fragments bands in proband and mother are of the same size, 865 bp for the inv2p16.1 
fragment and 640 bp for the inv2q14.3 fragment. The control fragments are sized 862 bp and 645 bp, 
respectively, for the short and long arm breakpoint. The father lacks the alteration, given the observed 





Figure 3.6. Amplification of chromosome 2 inversion junction and control fragments, for proband and parents, on 
agarose gel electrophoresis.  
A) Amplification of the inv2p16.1 junction and control fragments. A 865 bp junction fragment (lanes 1-4) and a 862 bp 
control fragment (lanes 5-8) were obtained for proband and mother. 
B) Amplification of the inv2q14.3 junction and control fragments. A 640 bp junction fragment (lanes 10-13) and a 645 bp 
control fragment (lanes 14-17) were obtained for proband and mother. 
(Mk - HyperLadder 50 bp DNA marker; NC - negative control; P – proband; M – proband’s mother; F – proband’s father). 
 
 
Junction fragment amplicons from both proband and his mother were then sequenced by Sanger 
sequencing, in order to identify the inversion breakpoints with nucleotide resolution. Analysis of the 
junction fragments determined the inversion breakpoints exact genomic location. Furthermore, the 
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breakpoints were found to be the same in both proband and his mother, and no nucleotide differences 
were identified. 
 
The inversion breakpoints are located at position g.55,935,064 (GRCh37) and g.123,767,685 
(GRCh37) (Figure 3.7.). By convention, the reported breakpoint was defined as being the last 
nucleotide able to be read in 5’-3’ orientation of the junction fragment, reason why the 5bp deletion 
was shown as belonging to inv2q14.3 in Figure 3.7.. In term of mechanism, the deleted sequence 





Figure 3.7. Nucleotide sequences of inversion junction fragments aligned against the reference genome sequence.  
A) Sequence alignment of inv2p16.1 junction fragment. 
B) Sequence alignment of inv2q14.3 junction fragment. A deletion of 5 bases was found, indicated underlined in lower case.  
On top, the schematic representation of the chromosome 2 inversion, indicating the breakpoint locations. Sequences inside 
the inversion are in grey, while outside are in black. Junction fragments are shown below the electropherogram. Wild-type 
chromosome reference sequence at bottom, with their genomic position indicated below. Vertical lines indicate identical 




The next-generation cytogenetics and sequence-based nomenclature of the inv(2)(p16.1;q14.3) is 
seq[GRCh37] inv(2)(pter→2p16.1(55,935,06{1-3})::2q14.3(123,767,68{3-1})→2p16.1(55,935,06{5-
4})::2q14.3(123,767,68{4-5})→qter) (Ordulu et al. 2014, http://boston.bwh.harvard.edu/input.html). 
The numbers between the braces reflect the uncertainty of the exact breakpoint. 
 
It is known that segmental duplications can act as hotpots for rearrangements. In the case of the 
inversion, there are no such features reported nearby the breakpoints. However, interspersed elements 
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repeats, both long (LINE) and short (SINE), were found just a couple hundred bases from the 
inv2p16.1 breakpoint, on both sides. The inv2q14.3 breakpoint actually falls inside a LINE called 
L1M2 (chr2:123,762,071-123,768,419, GRCh37). These repeats have been shown to promote 
instability and the formation of DNA double-strand breaks (Gilling et al. 2006) and could play a role 
behind the origin of this rearrangement. 
 
The array CGH results of the proband identified no genomic imbalances nor loss of heterozygosity at 
the inversion breakpoint regions. 
 
This 68 Mb pericentric chromosomal inversion was initially reported to span from 2p21 to 2q21.1 in 
the proband and his mother. However, data derived from NGS was able to determine the breakpoints 
location with incomparably higher resolution, and found that they are actually in the neighboring 
cytobands p16.1 and q14.3, respectively. Sanger sequencing of the junction fragments identified the 
breakpoints with nucleotide resolution. Therefore, the subject’s karyotype was updated and redefined 
as 46, XY, inv(2)(p16.1q14.3)mat. It is currently unknown whether the inversion in the mother was 
inherited or de novo. 
 
There are currently no pericentric inversion with breakpoints within 5 Mb of those of 
inv(2)(p16.1q14.3) reported in the dbVar database. Only a small inversion of 32 kb was reported 
within 1 Mb of the short arm breakpoint, located at ch2:55,129,764-55,161,515 (GRCh37), without 
phenotypical data available (Kidd et al. 2008). 
 
 
3.5.3. Identification of possible candidate genes from the inversion breakpoint 
regions  
 






Figure 3.8. Physical map across the inv2p16.1 breakpoint region.  
Red horizontal lines with folded arrow indicate the position of genes while grey horizontal lines indicate RNA, in sense 
(above the map) and antisense (below the map) orientation. Underlined are OMIM genes with phenotypical description 
available. Black vertical arrow indicate the breakpoint location. Grey horizontal arrow represent primers. Reference genome 
assembly GRCh37. 
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The nearest flanking gene is located 14 kb away at 5’, the protein-coding Polyribonucleotide 
Nucleotidyltransferase 1 (PNPT1; chr2:55,861,198-55,921,045, GRCh37; OMIM *610316). It codes 
for a RNA-binding protein, predominantly mitochondrially localized, implicated in numerous RNA 
metabolic processes (von Ameln et al. 2012). Homozygous mutation in PNPT1 has been associated 
with combined oxidative phosphorylation deficiency (COXPD13; OMIM #614932), in which the 
mutated gene impairs normal import of several RNA species into mitochondria, causing a defect in 
mitochondrial translation and resulting in mitochondrial respiratory chain deficiency (Vedrenne et al. 
2012). The gene is also associated with deafness (DFNB70; OMIM #614934), concordant to the 
expression studies in mice. Some degree of hearing impairment is typical in patients with a mutated 
PNPT1. Both diseases are autosomal recessive. Since metabolic studies gave normal results and no 
hearing impairment was detected, it appears that, although so close to the breakpoint, PNPT1 was not 
significantly affected by it. In mouse models, this gene is highly expressed in the cochlea and skeletal 
muscle. 
 
The gene EGF-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1; chr2:56,093,097-
56,151,298, GRCh37; OMIM *601548), also known as Fibrillin-Like (FBNL), is located about 172 kb 
from breakpoint at 3’. The extracellular matrix protein coded by EFEMP1 is very similar to fibrillin, 
essential for the formation of elastic fibers in connective tissue and may function as a negative 
regulator of chondrocyte differentiation. It may have an important role in the maintenance of 
abdominal fascia, as Efemp1-/- knockout female mice has pelvic organ support impaired (Rahn et al. 
2009). Doyne honeycomb retinal dystrophy (DHRD; OMIM #126600), an autosomal dominant age-
related macular degeneration, is caused in a majority of reported cases by mutations in EFEMP1 (Fu 
et al. 2007). The proband, however, has no reported ocular defect. In mouse, its highest expression 
levels are in lung and esophagus, and lowest in heart and brain (Kobayashi et al. 2007). 
 
The inv2q14.3 breakpoint is located in a ‘gene-poor’ region, far away from protein coding genes, 




Figure 3.9. Physical map across the inv2q14.3 breakpoint region.  
Red horizontal lines indicate the position of genes while grey horizontal lines indicate RNA, in sense (above the map) and 
antisense (below the map) orientation. Underlined are OMIM genes with phenotypical description available. Black vertical 
arrow indicate the breakpoint location. Grey horizontal arrow represent primers. Reference genome assembly GRCh37. 
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Distanced 1.2 Mb proximal is the gene Translin (TSN; chr2:122,513,120-122,525,428, GRCh37; 
OMIM *600575), previously known as Recombination Hotspot-Associated Factor (RcHF1). Its coded 
protein specifically binds to the breakpoint junction translocations found in all acute lymphoblastic 
leukemia patients studied by Kasai and colleagues (1994). Since it is so connected to translocations, it 
was promptly renamed Translin (Aoki et al. 1995). TSN is involved in some degree with DNA 
damage repair as well as RNA trafficking in neurons (Li et al. 2008). Regarding human pathologies 
related to TSN, only in leukemia was it reported. The gene is most expressed in mouse subcutaneous 
adipose tissue. In knockout mice a wide range of behavior alterations, as well as lower reproductive 
success, were noticed (Stein et al. 2006). 
 
The gene Contactin-Associated Protein-Like 5 (CNTNAP5; chr2:124,782,863-125,672,953, GRCh37; 
OMIM *610519) is the closest protein-coding gene to the inv2q14.3 breakpoint, but is still distanced 
over 1 Mb distal. The gene CNTNAP5 produces a protein involved in cell adhesion and intercellular 
communication. Some studies propose that small cryptic mutations disrupting CNTNAP5 may be 
linked to susceptibility to dyslexia and ASD (An et al. 2014; Pagnamenta et al. 2010). It has increased 
expression in mice’s nervous system and most predominantly expressed in subcutaneous adipose cells 
(Traut et al. 2006). 
 
The remaining protein-coding genes in inv2p16.1 and inv2q14.3 regions were also studied, namely 
the Coiled-Coil Domain Containing 85A (CCDC85A; chr2:56,411,258-56,613,309, GRCh37), 
Glycophorin C (GYPC; chr2:127,413,510-127,454,250, GRCh37; OMIM *110750) and 
Uncharacterized LOC101929926 (AC114783 or LOC101929926; ch2:127,656,458-127,659,673, 
CRCh37). However, they have either little information publicly available or have no reports that 
supported them as possibly involved with the malformation syndrome in proband, either due to their 
function, expression in mouse or associated clinical phenotypes. For example, mutations in gene 
GYPC are mainly associated with resistance to malaria. Consequently, these genes are likely excluded 
as being involved in the observed phenotype. 
 
For structural chromosomal anomalies, the prime aspect in determining their significance is where the 
breakpoints are located and if these interrupt a candidate gene or lead to disruption of their 
transcriptional regulation (Feuk 2010). This is not the case of this inversion, where the breakpoints 
junctions did not directly disrupt any gene, and no evidence of known regulatory elements sitting at 
both coordinates was found. 
 
 
3.5.4. Gene expression analysis for the inversion 
 
The expression levels obtained from HTA 2.0 and HuGene 1.0 ST of genes flanking the inversion 2 
breakpoints, as well as nearby protein-coding genes, are shown in Table 3.5.  
 
The levels in the proband appear to be not significantly different from that of the control group. The 
standard deviation in these genes are high compared to that from HuGene 1.0 ST, possibly due to 






Table 3.5 Expression levels of genes in the inversion 2 breakpoints regions 
Numbers indicate probe signal intensity. 
 
 
Summarizing the results so far, the chromosome 2 inversion is confirmed to be maternal in heritage. 
The breakpoints do not disrupt genes, with one of the breakpoints located in a gene poor region. The 
protein-coding genes flanking the inversion were not considerably affected by the rearrangement in 
terms of their expression levels in LCL. The remaining genes nearby the breakpoints are also unlikely 
to be related to the phenotype. It appears that existence of this pericentric inversion by itself should 
not have caused the observed malformation syndrome. 
 
Taking these findings into consideration, the question of whether the inversion is polymorphic in 
nature, but at a low frequency, is raised.  
 
Additionally, the existence of environmental factors during embryogenesis that may have led to the 




Gene Proband C1 C2 C3 C4 C5 
Control HuGene 1.0 ST 
Mean SD Mean SD 
inv2p16.1 region          
PNPT1 9.66 10.8 11.05 11.00 10.32 9.64 10.56 0.59 9.29 0.33 
EFEMP1 3.88 6.27 4.89 5.01 4.95 3.76 4.98 0.89 3.49 0.13 
inv2q14.3 region          
TSN 8.83 10.08 10.17 9.79 9.95 8.83 9.76 0.54 8.59 0.26 
CNTNAP5 3.13 4.07 4.16 4.06 4.13 3.13 3.91 0.44 3.41 0.17 
GYPC 5.50 8.89 6.63 7.35 7.84 6.46 7.43 0.99 7.29 0.41 
AC114783 2.85 3.88 4.48 4.1 3.88 2.85 3,84 0,60     - - 
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4. CONCLUSIONS AND FUTURE WORK 
 
This study aimed to identify the candidate genes and molecular alterations behind a severe 
malformation syndrome. The case study focuses in an individual with an apparently balanced 
pericentric inversion defined by cytogenetic analysis as inv(2)(p21;q21.1)mat. 
 
First, imbalanced genomic anomalies were screened in the proband, using genomic arrays. A 
plausible candidate for pathogenesis was the 590 kb duplication in 2q21.1. A very similar 610 kb 
duplication was discovered in proband’s father, who is phenotypically normal, being supposedly the 
same alteration. The 590 kb duplication affects several OMIM genes, but only one gene, CCDC115, 
has been associated with a clinical phenotype to date, but is unrelated to the proband’s malformation 
syndrome. Expression studies found that their levels appear not significantly different from the 
control group. The region is also reported with several CNV of no or uncertain pathogenic 
significance, as well as segmental duplications. Taking these findings into account, especially due to 
its paternal heritage, the 2q21.1 duplication by itself is most likely nonpathogenic.     
 
Concerning the chromosome 2 inversion, long-insert whole genome sequencing was performed to 
identify the inversion breakpoints as well as any possible cryptic alterations. The results obtained 
from NGS data analysis provided deeper understanding of the balanced rearrangement in study and 
expedited the determination of breakpoints. NGS proved to be an invaluable method for the 
determination of inversion breakpoints, since it was able to identify the chromosome 2 inversion with 
much higher resolution than with cytogenetic studies. The proband’s karyotype was redefined to 46, 
XY, inv(2)(p16.1q14.3)mat. The breakpoints were determined at nucleotide resolution by sequencing 
of the junction fragments. Also, familiar segregation study allowed the confirmation that the 
inversions found in the proband and proband’s mother is identical. This result supports the refutation 
of disease-causing effect of the inversion if considering the rearrangement by itself.  
 
Furthermore, the inversion does not disrupt any gene and the publicly accessible information on 
breakpoints flanking genes, such as their biological function and associated pathologies, gave little 
support to possible phenotype-genotype relationship with the proband’s clinical features. 
Additionally, expression studies were undertaken and the data suggest that genes closest to the 
breakpoints do not have a significantly altered expression level. It is unlikely that these genes alone 
have a significant role in pathogenesis. 
 
Also, by array CGH, no CNV nor loss of heterozygosity were found in the inversion breakpoints 
regions, or in their corresponding cytoband. 
 
Considering the data obtained using these methodologies, is unlikely that the two rearrangements here 
described, alone, could be behind the observed clinical phenotype in the proband, since the parents are 
phenotypically normal. In the end, the inversion was excluded as the sole explanation of the severe 
malformation syndrome. Consequently, the question of whether the inversion is polymorphic in 
nature, but at a low frequency, is raised. It can’t be excluded the influence on the congenital 
malformation of environmental factors during embryogenesis. 
 
At the moment, genetic etiology of the congenital malformation is yet to be determined. Thus, further 
studies are warranted for the identification of the molecular alterations responsible for the observed 
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congenital malformation syndrome. Also, expanding the gene expression analysis genome-wide could 
help elucidate the proband's phenotype. 
 
It is possible that the combination of chromosome 2 inversion and the duplication at 2q21.1 could lead 
to disease, even if they alone appear insufficient. More studies are necessary to infer whether the 
phenotype could have been exacerbated by the interaction between of them, or between yet to be 
identified alterations, like the phenomenon previously described by David et al. (2015).  
 
Similarly, it is possible that the malformation syndrome could be due to cryptic mutations undetected 
by currently utilized methodologies. Therefore, exome sequencing is proposed for this task. Whole-
exome sequencing is traditionally used to detect single-nucleotide variants and small indels. Since 
exome sequencing focuses in the coding regions with its capture-based approach, it has a very high 
coverage, increasing the confidence in any detected point mutations. Additionally, it has the 
advantage of being faster and more economically accessible than whole-genome sequencing (Yang et 
al. 2016). The downside is the complexity of data analysis, sometimes yielding inconclusive findings. 
Nonetheless, by sequencing the proband’s exome, this highly complex approach should be able to 
detect alterations missed by other methods and possibly identify the molecular cause behind the 
clinical phenotype. 
 
Even though not the object of this thesis, preparation of large-insert whole genome sequencing 
libraries based on the protocol by Talkowski et al. (2011) and its updated version (Hanscom and 
Talkowski 2014) was implemented in the research group. This would be of particular importance for 
large scale application of this approach for identification of structural chromosomal anomalies that 
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